Marex Group plc (‘Marex’ or the 'Group’; Nasdaq: MRX), a
diversified global financial services platform, announces strong
results for the six months ended 30 June 2024, and a positive
outlook for the full year.
H1 2024 Highlights
Financial Highlights: ($m) |
3 months ended 30 June 2024 |
|
3 months ended 31 March 2024 |
|
Change1 |
|
6 months ended 30 June 2024 |
|
6 months ended 30 June 2023 |
|
Change1 |
Reported |
|
|
|
|
|
|
|
|
|
|
|
Revenue |
422.1 |
|
365.8 |
|
15% |
|
787.9 |
|
622.4 |
|
27% |
Profit Before Tax |
80.1 |
|
58.9 |
|
36% |
|
139.0 |
|
109.5 |
|
27% |
Profit Before Tax Margin (%) |
19% |
|
16% |
|
300bps |
|
18% |
|
18% |
|
— bps |
Profit After Tax |
59.3 |
|
43.6 |
|
36% |
|
102.9 |
|
80.8 |
|
27% |
Return on Equity (%) |
29% |
|
23% |
|
600bps |
|
25% |
|
23% |
|
200 bps |
Basic Earnings per Share ($)2 |
0.81 |
|
0.60 |
|
35% |
|
1.41 |
|
1.13 |
|
25% |
Diluted Earnings per Share ($)2 |
0.76 |
|
0.56 |
|
36% |
|
1.32 |
|
1.06 |
|
25% |
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted3 |
|
|
|
|
|
|
|
|
|
|
|
Operating Profit3 |
91.5 |
|
67.7 |
|
35% |
|
159.2 |
|
124.5 |
|
28% |
Operating Profit Margin (%)3 |
22% |
|
19% |
|
300bps |
|
20% |
|
20% |
|
— bps |
Operating Profit after Tax Attributable to Common Equity3 |
66.8 |
|
48.9 |
|
37% |
|
115.7 |
|
90.1 |
|
28% |
Return on Operating Profit after Tax Attributable to Common Equity
(%)3 |
37% |
|
29% |
|
800bps |
|
32% |
|
30% |
|
200 bps |
Adjusted Earnings per Share($)2,3 |
0.96 |
|
0.74 |
|
30% |
|
1.70 |
|
1.37 |
|
24% |
Adjusted Diluted Earnings per Share ($)2,3 |
0.90 |
|
0.69 |
|
30% |
|
1.59 |
|
1.29 |
|
23% |
1. 1% Change is calculated on numbers presented to the nearest
tenth of a million.
2. Weighted average number of shares have been restated as
applicable for the reverse share split (refer to note 12 in our
condensed consolidated financial statements furnished to the SEC on
Form 6-K on 14 August 2024 for further detail).
3. These are non-IFRS financial measures. See Appendix 1
“Non-IFRS Financial Measures and Key Performance Indicators” for
additional information and for a reconciliation of each such IFRS
measure to its most directly comparable non-IFRS measure.
- Strong performance in H1
2024: Successful execution of our growth strategy and
positive market conditions supported strong performance across all
business segments in the first half of the year
- Exceptionally strong
performance in the second quarter: Unusual conditions
in the metals market benefited Market Making, as we supported our
clients with access to liquidity, increasing volumes on our
platform, while maintaining our prudent approach to risk
- Continued progress with our
growth initiatives: We look to grow
our platform and expand our client base, building out our product
capabilities and geographic reach, diversifying our business and
expanding our addressable market
- Prudent approach to capital
and funding: Growing our capital base and
significant liquidity headroom maintained
- Positive outlook:
Based on the strong performance in the first half and positive
momentum in our business segments, we anticipate full year Adjusted
Operating Profit to be approximately $280m to $290m for the year
ending 31 December 2024, assuming more normalised market conditions
for the remainder of the year
- Progressive dividend policy
announced: The Group Board expects to pay a dividend
on a quarterly basis. Initial dividend of $10m or $0.14 per share
to be paid in the third quarter of 2024
Ian Lowitt, Group Chief Executive Officer, commented:
“Marex delivered strong results in the first half of 2024,
supported by organic growth and the ongoing integration of our
recent acquisitions, with double digit growth in revenue and
Adjusted Operating Profit across all our business segments. We
continue to benefit from our diversified global platform, which has
enabled us to grow our client base, add additional products across
an expanded geographic footprint, and increase the amount of
business we do with our clients.
We saw an exceptional performance in the second quarter, where
in addition to growing in all of our business segments, we were
able to take advantage of the unusual opportunities presented in
the metals market resulting from amended guidance from the LME
regarding Russian metals. We were able to support our clients as a
market maker, providing access to liquidity in this active
market. This demonstrates Marex's ability to perform
well in a favourable environment, while continuing to operate
within our strict risk parameters.
The outlook for Marex remains positive and we believe we are on
track for a tenth year of sequential growth. We anticipate full
year Adjusted Operating Profit to be approximately $280m to $290m,
assuming more normalised market conditions in H2
2024, following the strong performance in the first half,
momentum in our businesses and further progress executing our
growth strategy."
|
|
|
|
Conference Call
Information:Marex’s management will host a conference call to
discuss the Group's financial results today, 14 August 2024, at 9am
Eastern Time. A live webcast of the call can be accessed from
Marex’s Investor Relations website. An archived version will be
available on the website after the call. To participate in the
Conference Call, please register at the link here
https://register.vevent.com/register/BId22ef6b4029c4b8caacf93432d9ecf7f |
|
|
|
|
Financial Review
Marex has delivered another period of strong performance, driven
by a combination of organic growth and the benefits of recent
acquisitions including Cowen's Prime Services and Outsourced
Trading business ('Cowen'), which have led to increased client
activity on our global platform. This performance has been
delivered in an environment of very supportive market
conditions, notably in the metals markets, as well as continued
high interest rates.
The following table presents summary financial results and other
data as of the dates and for the periods indicated:
Summary Financial Results
|
3 months ended 30 June 2024 |
|
3 months ended 31 March 2024 |
|
|
|
6 months ended 30 June 2024 |
|
6 months ended 30 June 2023 |
|
|
|
$m |
|
$m |
|
Change |
|
$m |
|
$m |
|
Change |
– Net commission income |
208.4 |
|
218.9 |
|
(5)% |
|
427.3 |
|
347.2 |
|
23% |
– Net trading Income |
136.5 |
|
106.2 |
|
29% |
|
242.7 |
|
212.5 |
|
14% |
– Net interest income |
65.4 |
|
35.6 |
|
84% |
|
101.0 |
|
60.0 |
|
68% |
– Net
physical commodities income |
11.8 |
|
5.1 |
|
131% |
|
16.9 |
|
2.7 |
|
526% |
Revenue |
422.1 |
|
365.8 |
|
15% |
|
787.9 |
|
622.4 |
|
27% |
Front office costs |
(224.8) |
|
(210.1) |
|
7% |
|
(434.9) |
|
(335.2) |
|
30% |
Control and support costs |
(100.4) |
|
(80.6) |
|
25% |
|
(181.0) |
|
(146.3) |
|
24% |
Recovery/(provision) for
credit losses |
1.9 |
|
0.3 |
|
533% |
|
2.2 |
|
(4.5) |
|
(149)% |
Depreciation and
amortisation |
(7.7) |
|
(7.8) |
|
(1)% |
|
(15.5) |
|
(14.9) |
|
4% |
Other
Income and share of results of associates |
0.4 |
|
0.1 |
|
300% |
|
0.5 |
|
3.0 |
|
(83)% |
Adjusted Operating Profit1 |
91.5 |
|
67.7 |
|
35% |
|
159.2 |
|
124.5 |
|
28% |
Adjusted Operating Profit
Margin1 |
22% |
|
19% |
|
300 bps |
|
20% |
|
20% |
|
0 bps |
Adjusting items2 |
(11.4) |
|
(8.8) |
|
30% |
|
(20.2) |
|
(15.0) |
|
35% |
Reported Profit Before Tax |
80.1 |
|
58.9 |
|
36% |
|
139.0 |
|
109.5 |
|
27% |
Tax |
(20.8) |
|
(15.3) |
|
36% |
|
(36.1) |
|
(28.7) |
|
26% |
Reported Profit After Tax |
59.3 |
|
43.6 |
|
36% |
|
102.9 |
|
80.8 |
|
27% |
1. These are non-IFRS financial measures. See Appendix 1
“Non-IFRS Financial Measures and Key Performance Indicators” for
additional information and for a reconciliation of each such IFRS
measure to its most directly comparable IFRS measure.
2. Refer to Appendix 1 “Non-IFRS Financial Measures and Key
Performance Indicators” for additional information.
Profit Before Tax increased 27% to $139.0m from $109.5m in H1
2023 reflecting strong performance in the first half of the
year.
Revenue increased by 27% to $787.9m in H1 2024 from $622.4m in
H1 2023, reflecting favourable market conditions, strong underlying
growth and the benefits of our acquisitions.
Net commission income increased by 23% to $427.3m for H1 2024
from $347.2m in H1 2023. The increase was driven mainly by Agency
and Execution, which increased by 32% compared to H1 2023,
reflecting increased customer activity in Energy, as well as from
our acquisition of Cowen. Net commission income was also higher in
our Clearing segment which increased by 9% versus H1 2023, driven
by our Metals and Agriculturals businesses.
Net trading income rose by 14% to $242.7m for H1 2024 from
$212.5m for H1 2023. This was driven by our Metals business within
our Market Making segment, reflecting exceptional market conditions
and market sentiment across Copper, Aluminium and Nickel, following
revised guidance on Russian metals from the LME. Net trading
income also increased by 36% to $112.0m in Hedging and Investment
Solutions, as demand grew for commodity hedging and financial
product services.
Net interest income increased by 68% to $101.0m for H1 2024 from
$60.0m for H1 2023. This growth reflected the benefit of higher
average fed fund interest rates, as well as the introduction of
Cowen business in December 2023. In addition, it reflected the
reinvestment of maturing assets at higher yields. These benefits
were partly offset by higher client payouts.
Net interest income:
|
6 months ended 30 June 2024 |
|
6 months ended 30 June 2023 |
|
Change |
Average Fed Funds
% |
5.33% |
|
4.76% |
|
57bps |
|
|
|
|
|
|
Average balances
($bn) |
13.4 |
|
13.5 |
|
(0.1) |
Interest Income ($m) |
331.5 |
|
251.1 |
|
80.4 |
|
|
|
|
|
|
Interest paid out ($m) |
(126.0) |
|
(111.4) |
|
(14.6) |
|
|
|
|
|
|
Interest on balances
($m) |
205.5 |
|
139.7 |
|
65.8 |
Net Yield on balances % |
3.1% |
|
2.1% |
|
100bps |
|
|
|
|
|
|
Average notional debt
securities ($bn) |
2.6 |
|
2.0 |
|
0.6 |
Yield % |
7.9% |
|
8.0% |
|
(10)bps |
Interest expense
($m) |
(104.5) |
|
(79.7) |
|
(24.8) |
|
|
|
|
|
|
Net Interest Income ($m) |
101.0 |
|
60.0 |
|
41.0 |
Net physical commodities income increased by 526% to $16.9m for
H1 2024 from $2.7m for H1 2023. This increase was primarily due to
an increase in sales volumes from physical recycled metal and
physical oil sales, largely driven by growth in our recycled metals
business and the addition of physical oil broking capabilities.
Front office costs represent staff, systems and infrastructure
costs associated with running our revenue generating operations.
These costs increased 30% to $434.9m for H1 2024, largely
reflecting a 27% increase in average front office headcount driven
by recent acquisitions, as well as organic growth.
Control and Support costs primarily reflect staff and property
related costs, along with professional fees and other
administrative expenses associated with the support functions.
These costs increased 24% to $181.0m in H1 2024, primarily
reflecting investment in our Finance, Risk and Compliance
functions, to ensure we continually invest in our systems and
processes to support future sustainable growth, as well as
integrating additional Control & Support employees as part of
recent acquisitions. Total control and support average FTE grew 21%
to 1,030 at the end of H1 2024.
Adjusting items grew by 34% to $20.1m from $15.0m. These costs
are primarily related to corporate activities and are recognised
within our corporate segment. Adjusting items increased mainly due
to costs incurred in preparation for and associated with our
successful IPO, as well as activities related to our shareholders
representing dividend like contributions made to participants
within share based payment schemes.
As a result of the revenue and cost trends noted above, Adjusted
Operating Profit increased 28% to $159.2m for H1 2024 and Adjusted
Operating Profit Margins remained at 20%, in line with H1 2023. In
addition, as a result of the revenue, cost trends and adjusting
items noted above, Profit Before Tax Margins remained at 18% in
line with H1 2023.
Segmental performance
Clearing
Marex provides Clearing services across the range of energy,
commodity and financial markets. We act as principal for our
clients and provide access to over 58 exchanges globally.
Our Clearing business performed well in H1 2024, benefiting from
higher levels of client activity on our platform, with 538m
contracts cleared in the first half of 2024 which is 28% higher
than in the same period in 2023.
Revenue increased 16% to $224.9m in H1 2024, up from $193.9m in
H1 2023, driven by net interest income which rose by 25% to $87.0m
from $69.4m in H1 2023 reflecting the benefit of higher interest
rates. Net commission income increased 9% to $135.6m. Revenue
growth was generated from our established businesses, notably in
Metals reflecting market conditions, as well as benefiting from our
growth initiatives, notably in Australia, Singapore and in our
Prime Services offerings.
Revenue growth was supported by investment in staff with average
headcount increasing by 13% in H1 2024 to 295.
Adjusted Operating Profit increased by 21% in H1 2024 to
$119.0m, from $98.6m. Adjusted Operating Profit Margins have
increased by 200bps to 53% from 51% in H1 2023.
|
6 months ended 30 June 2024 |
|
6 months ended 30 June 2023 |
|
|
|
$m |
|
$m |
|
Change |
Net commission income |
135.6 |
|
124.1 |
|
9% |
Net interest income |
87.0 |
|
69.4 |
|
25% |
Other
revenue |
2.3 |
|
0.4 |
|
475% |
Revenue |
224.9 |
|
193.9 |
|
16% |
Front office costs |
(72.4) |
|
(56.7) |
|
28% |
Control and support costs |
(33.4) |
|
(34.8) |
|
(4%) |
Recovery/(provision) for
credit losses |
0.1 |
|
(3.7) |
|
(103%) |
Depreciation and amortisation |
(0.2) |
|
(0.1) |
|
100% |
Adjusted Operating Profit
($m)1 |
119.0 |
|
98.6 |
|
21% |
Adjusted Operating Profit
Margin1 |
53% |
|
51% |
|
200 bps |
|
|
|
|
|
|
Front office headcount
(No.)2 |
305 |
|
262 |
|
16% |
Contracts cleared (m) |
533.1 |
|
419.0 |
|
27% |
Market
volumes (m) |
5,627.0 |
|
5,170.0 |
|
9% |
1. These are non-IFRS financial measures. See Appendix 1
“Non-IFRS Financial Measures and Key Performance Indicators” for
additional information and for a reconciliation of each such IFRS
measure to its most directly comparable IFRS measure.
2. The headcount is as at the end of the period.
Agency and Execution
Agency and Execution provides essential liquidity and execution
services to our clients primarily in the energy and financial
securities markets.
Revenue increased substantially to $332.6m in H1 2024 compared
to $252.3m in H1 2023, reflecting the positive market conditions in
the energy markets, and the benefit of recent acquisitions,
primarily Cowen, which increased our capabilities in financial
securities.
Adjusted Operating Profit increased to $44.9m in H1 2024 from
$26.9m in H1 2023 reflecting revenue growth and improved Adjusted
Operating Profit Margins, which increased to 13% for H1 2024, up
from 11% in H1 2023.
Securities
Our presence in the financial markets is growing as we integrate
and optimise recent acquisitions, allowing Marex to diversify its
asset class coverage away from traditional commodity markets. The
key revenue streams for our agency and execution financial
securities business are equity derivatives, primarily index options
and fixed income, including corporate and government bonds. Revenue
increased by 25% to $188.5m during H1 2024, compared to $150.2m
during H1 2023, primarily as a result of the benefit of the Cowen
acquisition which completed in December 2023 and OTCex Group which
completed on 1 February 2023.
Energy
Our energy division provides essential liquidity to clients by
connecting buyers and sellers in the opaque OTC energy markets to
facilitate price discovery. We have leading positions in many of
the markets we operate in, including key gas and power markets in
Europe; environmental, petrochemical and crude markets in North
America; and fuel oil, LPG (liquefied petroleum gas) and
mid-distillates globally.
We achieve this through the breadth and depth of the service we
offer to customers, including market intelligence for each product
we transact in, based on the extensive knowledge and experience of
our teams.
Revenue increased 42% in H1 2024 to $143.3m, compared to $101.0m
in H1 2023. This strong growth was a reflection of continued
improvement in activity levels in European Energy markets, good
demand for our environmentals offering as we continue to support
our clients in the energy transition, as well as investment in new
desks and capabilities.
|
6 months ended 30 June 2024 |
|
6 months ended 30 June 2023 |
|
|
|
$m |
|
$m |
|
Change |
Securities |
188.5 |
|
150.2 |
|
25% |
Energy |
143.3 |
|
101.0 |
|
42% |
Other
revenue |
0.8 |
|
1.1 |
|
(27)% |
Revenue |
332.6 |
|
252.3 |
|
32% |
Front office costs |
(258.8) |
|
(197.3) |
|
31% |
Control and support costs |
(28.1) |
|
(27.2) |
|
3% |
Provision for credit
losses |
(0.3) |
|
(0.6) |
|
(50)% |
Depreciation and
amortisation |
(0.5) |
|
(0.4) |
|
25% |
Other
Income and share of results of associates |
— |
|
0.1 |
|
(100)% |
Adjusted Operating Profit
($m)1 |
44.9 |
|
26.9 |
|
67% |
Adjusted Operating Profit
Margin1 |
13% |
|
11% |
|
200 bps |
|
|
|
|
|
|
Front office headcount
(No.)2 |
659 |
|
546 |
|
21% |
Marex volumes: Energy (m) |
29.2 |
|
17.6 |
|
66% |
Marex volumes: Securities
(m) |
140.9 |
|
121.1 |
|
16% |
Market volumes: Energy
(m) |
840.0 |
|
674.0 |
|
25% |
Market
volumes: Securities (m) |
5,314.0 |
|
5,033.0 |
|
6% |
1. These are non-IFRS financial measures. See Appendix 1
“Non-IFRS Financial Measures and Key Performance Indicators” for
additional information and for a reconciliation of each such IFRS
measure to its most directly comparable IFRS measure.
2. The headcount is as at the end of the period.
Market Making
Our Market Making business provides direct liquidity to our
clients across a variety of products, primarily in the energy,
metals and agriculture markets. This ability to make prices and
trade as principal in a wide variety of energy, environmentals and
commodity markets differentiates us from many of our peers.
Revenue increased by 23% to $111.3m in H1 2024, from $90.7m in
H1 2023. This was driven by Metals trading which benefited from
unusual market conditions across Copper, Aluminium, Nickel,
following revised guidance on Russian metals from the LME.
Higher revenue in Metals was partly offset by lower revenue in
Agriculturals and Energy in H1 2024. Agriculturals had a strong
performance in H1 2023 and there was lower volatility in Energy in
H1 2024. Revenue growth was also supported by Front Office hiring,
with average headcount increasing by 14% to 104 in H1 2024.
Adjusted Operating Profit increased by 59% in H1 2024 to $39.5m,
reflecting strong revenue growth, which also led to Adjusted
Operating Profit Margins increasing to 35% from 27%.
|
6 months ended 30 June 2024 |
|
6 months ended 30 June 2023 |
|
|
|
$m |
|
$m |
|
Change |
Metals |
68.4 |
|
33.2 |
|
106% |
Agriculture |
14.3 |
|
22.0 |
|
(35)% |
Energy |
13.8 |
|
17.8 |
|
(22)% |
Securities |
14.8 |
|
17.7 |
|
(16)% |
Revenue |
111.3 |
|
90.7 |
|
23% |
Front office costs |
(55.2) |
|
(48.7) |
|
13% |
Control and support costs |
(16.4) |
|
(18.0) |
|
(9)% |
Depreciation and
amortisation |
(0.2) |
|
(0.1) |
|
100% |
Other
Income and share of results of associates |
— |
|
0.9 |
|
(100)% |
Adjusted Operating Profit
($m)1 |
39.5 |
|
24.8 |
|
59% |
Adjusted Operating Profit
Margin1 |
35% |
|
27% |
|
800 bps |
|
|
|
|
|
|
Front office headcount
(No.)2 |
107 |
|
90 |
|
19% |
Marex volumes: Metals (m) |
17.1 |
|
13.2 |
|
30% |
Marex volumes: Agriculture
(m) |
18.1 |
|
14.2 |
|
27% |
Marex volumes: Energy (m) |
0.9 |
|
1.0 |
|
(10)% |
Marex volumes: Financials
(m) |
1.0 |
|
2.0 |
|
(50)% |
Market volumes: Metals
(m) |
217.0 |
|
168.0 |
|
29% |
Market volumes: Agriculture
(m) |
297.0 |
|
269.0 |
|
10% |
Market volumes: Energy
(m) |
839.0 |
|
675.0 |
|
24% |
Market
volumes: Financials (m) |
5,314.0 |
|
5,033.0 |
|
6% |
1. These are non-IFRS financial measures. See Appendix 1
“Non-IFRS Financial Measures and Key Performance Indicators” for
additional information and for a reconciliation of each such IFRS
measure to its most directly comparable IFRS measure.
2. The headcount is as at the end of the period.
Hedging and Investment Solutions
Our Hedging and Investment Solutions business provides high
quality bespoke hedging and investment solutions to our
clients.
Tailored commodity hedging solutions allow corporates to hedge
their exposure to movements in energy and commodity prices, as well
as currencies and interest rates, across a variety of different
time horizons. Our financial products offering allows investors to
gain exposure to a particular market or asset class, for example
equity indices, in a cost effective manner through
a structured product.
The business performed strongly during H1 2024, increasing
revenue by 36% to $86.0m, up from $63.3m in H1 2023. Revenue growth
occurred across all regions, with hedging solutions benefiting from
favourable market events and volatility in Cocoa and Coffee, while
financial products benefited from positive investor sentiment and
equity market performance. We continue to make good progress with
our growth initiatives, expanding our product coverage with custom
index and FX capabilities, and expanding our global footprint that
now includes Australia and the Middle East. As a result, we
continue to bring new clients onto our platform in both our Hedging
Solutions and Financial Products businesses.
Adjusted Operating Profit increased by 35% to $26.0m, up from
$19.2m in H1 2023, but Adjusted Operating Profit Margins remained
flat at 30% as we continued to invest in our people, with
average headcount increasing by 68% to 171 in H1 2024 compared with
H1 2023, as well as in our infrastructure and distribution network
to support future growth.
|
6 months ended 30 June 2024 |
|
6 months ended 30 June 2023 |
|
|
|
$m |
|
$m |
|
Change |
Hedging solutions |
42.5 |
|
29.7 |
|
43% |
Financial products |
43.5 |
|
33.6 |
|
29% |
Revenue |
86.0 |
|
63.3 |
|
36% |
Front office costs |
(48.2) |
|
(32.5) |
|
48% |
Control and support costs |
(13.3) |
|
(11.5) |
|
16% |
Recovery for credit
losses |
1.8 |
|
— |
|
100% |
Depreciation and amortisation |
(0.3) |
|
(0.1) |
|
200% |
Adjusted Operating Profit
($m)1 |
26.0 |
|
19.2 |
|
35% |
Adjusted Operating Profit
Margin1 |
30% |
|
30% |
|
0 bps |
|
|
|
|
|
|
Front office headcount
(No.)2 |
176 |
|
109 |
|
61% |
Structured notes balance ($m) |
2,112.8 |
|
1,589.3 |
|
33% |
1. These are non-IFRS financial measures. See Appendix 1
“Non-IFRS Financial Measures and Key Performance Indicators” for
additional information and for a reconciliation of each such IFRS
measure to its most directly comparable IFRS measure.
2. The headcount is as at the end of the period.
Corporate
The Corporate segment includes the Group's control and support
functions. Corporate manages the resources of the Group, makes
investment decisions and provides operational support to the
business segments. Corporate net interest income is derived through
earning interest on house cash balances placed at banks and
exchanges. Revenue for H1 2024 was $33.1m compared with $22.2m in
H1 2023, driven by net interest income reflecting higher average
Fed Fund interest rates.
|
6 months ended 30 June 2024 |
|
6 months ended 30 June 2023 |
|
|
|
$m |
|
$m |
|
Change |
Revenue |
33.1 |
|
22.2 |
|
49% |
Front office costs |
— |
|
— |
|
—% |
Control and support costs |
(90.2) |
|
(54.8) |
|
65% |
Recovery/(provision) for
credit losses |
0.6 |
|
(0.2) |
|
(400%) |
Depreciation and
amortisation |
(14.3) |
|
(14.2) |
|
1% |
Other
Income and share of results of associates |
0.6 |
|
2.0 |
|
(70%) |
Adjusted Operating Loss
($m)1 |
(70.2) |
|
(45.0) |
|
56% |
|
|
|
|
|
|
Control
and support headcount (No.)2 |
1,093 |
|
871 |
|
25% |
1. These are non-IFRS financial measures. See Appendix 1
“Non-IFRS Financial Measures and Key Performance Indicators” for
additional information and for a reconciliation of each such IFRS
measure to its most directly comparable IFRS measure.
2. The headcount is as at the end of the period.
Summary Financial Position
Our balance sheet continues to consist of high-quality liquid
assets which underpin client activity on our platform.
Total Assets have decreased from $17.6 billion at 31 December
2023 to $17.2 billion at 30 June 2024. This was driven by a
reduction in Reverse Repo which decreased from $3.2 billion at 31
December 2023 to $2.1 billion at 31 June 2024.
The reduction in reverse repurchase agreements, was partly
offset by Cash and Liquid Assets which increased from $4.5 billion
at 31 December 2023 to $5.1 billion at 30 June 2024, reflecting
liquidity generated from our structured notes program, as well as
underlying customer balance growth.
Securities balances increased from $4.0 billion at 31 December
2023 to $4.3 billion at 30 June 2024, due to growth in stock
borrowing and equity instruments driven by client activity.
The Group's equity base increased during the first half of the
year, with Total Equity increasing by 14% to $882.3m, up from
$775.9m as a result of strong profitability during the first half
of the year with Profit After Tax of $102.9m in H1 2024.
Furthermore, our share capital increased by $68.3m due to the
Primary Issuance completed during the IPO. These increases were
partly offset by a dividend payment of $44.1m in H1 2024.
|
30 June 2024 |
|
31 December 2023 |
|
|
|
|
|
Restated |
|
|
|
$m |
|
$m |
|
Change |
Cash & Liquid Assets1 |
5,135.2 |
|
4,465.9 |
|
15% |
Trade Receivables |
4,413.5 |
|
4,789.8 |
|
(8%) |
Reverse Repo Agreements |
2,104.3 |
|
3,199.8 |
|
(34%) |
Securities2 |
4,342.0 |
|
4,022.7 |
|
8% |
Derivative Instruments |
730.8 |
|
655.6 |
|
11% |
Other Assets3 |
242.5 |
|
258.2 |
|
(6%) |
Goodwill and Intangibles |
221.1 |
|
219.6 |
|
1% |
Total Assets |
17,189.4 |
|
17,611.6 |
|
(2%) |
Trade Payables |
7,128.6 |
|
6,785.9 |
|
5% |
Repurchase Agreements |
1,844.4 |
|
3,118.9 |
|
(41%) |
Securities4 |
4,299.7 |
|
4,248.1 |
|
1% |
Debt Securities |
2,446.3 |
|
2,216.3 |
|
10% |
Derivative Instruments |
496.8 |
|
402.2 |
|
24% |
Other
Liabilities5 |
91.3 |
|
64.3 |
|
42% |
Total Liabilities |
16,307.1 |
|
16,835.7 |
|
(3%) |
Total Equity |
882.3 |
|
775.9 |
|
14% |
1. Cash & Liquid Assets are cash and cash equivalents,
treasury instruments pledged as collateral and treasury instruments
unpledged.2. Securities assets are equity instruments and stock
borrowing.3. Other Assets are inventory, corporate income tax
receivable, deferred tax, investment in associate,
investments, right-of-use assets, and property plant and
equipment.4. Securities liabilities are stock lending and short
securities.5. Other Liabilities are deferred tax liability, lease
liability, provisions and corporation tax.
Liquidity
|
30 June 2024 |
|
31 December 2023 |
|
$m |
|
$m |
Total available liquid resources |
1,814.6 |
|
1,369.8 |
Liquidity headroom |
1,174.6 |
|
738.8 |
A prudent approach to capital and liquidity and commitment to
maintaining an investment grade credit rating are core principles
which underpin the successful delivery of our growth strategy. As
at 30 June 2024, the Group held $1,814.6m of total available liquid
resources, including the undrawn portion of the RCF, compared with
$1,369.8m at the end of 2023.
Group liquidity resources consist of cash and high-quality
liquid assets that can be quickly converted to meet immediate and
short-term obligations. The resources include non-segregated cash,
short-term money market funds and unencumbered securities
guaranteed by the U.S. Government. The Group also includes any
undrawn portion of its committed revolving credit facility (‘RCF’)
in its total available liquid resources. The unsecured revolving
credit facility of $150m remains undrawn as at 30 June 2024.
Liquidity headroom is based on the Group’s Liquid Asset
Threshold Requirement, which is prepared according to the
principles of the UK Investment Firms Prudential Regime (IFPR). The
requirement includes a liquidity stress impact calculated from a
combination of systemic and idiosyncratic risk factors.
Facilities held by operating subsidiaries, and which are only
available to that relevant subsidiary, have been excluded from
these figures as they are not available to the entire Group.
In February 2023, the Group successfully completed its inaugural
public senior bond issuance, raising €300m of additional liquidity.
The bonds have an annual coupon of 8.375%, mature in February 2028
and have been rated BBB- by both S&P and Fitch.
Regulatory capital
The Group is subject to consolidated supervision by the UK
Financial Conduct Authority and has regulated subsidiaries in
jurisdictions both inside and outside of the UK.
The Group is regulated as a MIFIDPRU investment firm under IFPR.
The minimum capital requirement as at 30 June 2024 was determined
by the Own Funds Threshold Requirement (‘OFTR’) set via an
assessment of the Group’s capital adequacy and risk assessment
conducted annually.
The Group and its subsidiaries are in compliance with their
regulatory requirements and are appropriately capitalised relative
to the minimum requirements as set by the relevant competent
authority. The Group maintained a capital surplus over its
regulatory requirements at all times.
Maintaining a prudent approach to capital and liquidity in order
to maintain an investment grade credit rating are core principles
which underpin the successful delivery of our growth strategy. The
Group manages its capital structure in order to comply with
regulatory requirements, ensuring its capital base is more than
adequate to cover the risks inherent in the business and to
maximise shareholder value through the strategic deployment of
capital to support the Group’s growth and strategic development.
The Group performs business model assessment, business and capital
forecasting, stress testing and recovery planning at least
annually. The following table summarises the Group’s capital
position as at 30 June 2024 and as at the year end:
|
30 June 2024 |
|
31 December 2023 |
|
$m |
|
$m |
Core equity Tier 1 Capital1 |
549.7 |
|
437.7 |
Additional Tier 1 Capital (net
of issuance costs) |
97.6 |
|
97.6 |
Tier 2
Capital |
2.5 |
|
3.1 |
Total Capital resources |
649.8 |
|
538.4 |
|
|
|
|
|
|
|
|
Own Funds Threshold Requirement2 |
235.1 |
|
235.1 |
Total Capital ratio3 |
276% |
|
229% |
1. Core Tier 1 Capital contains the unaudited results for the
period, which does not form a part of capital resources until they
are audited.
2. Own Funds Requirement presented as Own Funds Threshold
Requirement based on the latest Individual Capital and Risk
Assessment ('ICARA') process.
3. The Group’s total capital resources as a percentage of Own
Funds Requirement.
At 30 June 2024, the Group had a Total Capital Ratio of 276% (31
December 2023: 229%), representing significant capital headroom to
minimum requirements. The increase in the Total Capital Ratio
resulted from an increase in total capital resources due to profit
(unaudited) in H1 2024 and proceeds from the Primary Issuance
completed during the IPO in April 2024.
Dividend
Reflecting the Board of Directors confidence in the future
prospects of the Group, we announce the adoption of a progressive
dividend policy, with dividends to be paid on a quarterly basis
from the third quarter of 2024. The Board of Directors has approved
an initial dividend of $10m or $0.14 per share, expected to be paid
on 16 September 2024 to shareholders on record as at close of
business on 30 August 2024.
The decision to pay a dividend and the amount of dividend
however, remains at the discretion of our Board of Directors and
may be affected by various factors including our future earnings,
financial condition, capital requirements, share repurchase
activity, current and future planned strategic organic and
inorganic growth initiatives, levels of indebtedness, our
investment grade credit rating and other considerations our Board
of Directors deems relevant.
Forward looking statements:
This press release contains forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of
1995. All statements contained in this press release that do not
relate to matters of historical fact should be considered
forward-looking statements, including expected financial results
and Adjusted Operating Profit, expected growth and business plans,
expected market conditions and dividend payments. In some cases,
these forward-looking statements can be identified by words or
phrases such as “may,” “will,” “expect,” “anticipate,” “aim,”
“estimate,” “intend,” “plan,” “believe,” “potential,” “continue,”
“is/are likely to” or other similar expressions.
These forward-looking statements are subject to risks,
uncertainties and assumptions, some of which are beyond our
control. In addition, these forward-looking statements reflect our
current views with respect to future events and are not a guarantee
of future performance. Actual outcomes may differ materially from
the information contained in the forward-looking statements as a
result of a number of factors, including, without limitation:
subdued commodity market activity or pricing levels; the effects of
geopolitical events, terrorism and wars, such as the effect of
Russia’s military action in Ukraine, on market volatility, global
macroeconomic conditions and commodity prices; changes in interest
rate levels; the risk of our clients and their related financial
institutions defaulting on their obligations to us; regulatory,
reputational and financial risks as a result of our international
operations; software or systems failure, loss or disruption of data
or data security failures; an inability to adequately hedge our
positions and limitations on our ability to modify contracts and
the contractual protections that may be available to us in OTC
derivatives transactions; market volatility, reputational risk and
regulatory uncertainty related to commodity markets, equities,
fixed income, foreign exchange and cryptocurrency; the impact of
climate change and the transition to a lower carbon economy on
supply chains and the size of the market for certain of our energy
products; the impact of changes in judgments, estimates and
assumptions made by management in the application of our accounting
policies on our reported financial condition and results of
operations; lack of sufficient financial liquidity; if we fail to
comply with applicable law and regulation, we may be subject to
enforcement or other action, forced to cease providing certain
services or obliged to change the scope or nature of our
operations; significant costs, including adverse impacts on our
business, financial condition and results of operations, and
expenses associated with compliance with relevant regulations; and
if we fail to remediate the material weaknesses we identified in
our internal control over financial reporting or prevent material
weaknesses in the future, the accuracy and timing of our financial
statements may be impacted, which could result in material
misstatements in our financial statements or failure to meet our
reporting obligations and subject us to potential delisting,
regulatory investments or civil or criminal sanctions, and other
risks discussed under the caption “Risk Factors” in our final
prospectus filed pursuant to 424(b)(4) with the Securities and
Exchange Commission (the “SEC”) on 26 April 2024 and our other
reports filed with the SEC.
The forward-looking statements made in this press release relate
only to events or information as of the date on which the
statements are made in this press release. Except as required
by law, we undertake no obligation to update or revise publicly any
forward-looking statements, whether as a result of new information,
future events or otherwise, after the date on which the statements
are made or to reflect the occurrence of unanticipated events.
In addition, statements that “we believe” and similar statements
reflect our beliefs and opinions on the relevant subject. These
statements are based upon information available to us as of the
date of this press release, and while we believe such information
forms a reasonable basis for such statements, such information may
be limited or incomplete, and our statements should not be read to
indicate that we have conducted an exhaustive inquiry into, or
review of, all potentially available relevant information. These
statements are inherently uncertain, and investors are cautioned
not to unduly rely upon these statements.
Appendix 1
Non-IFRS Financial Measures and Key Performance
Indicators
This press release contains non-IFRS financial measures,
including Adjusted Operating Profit, Adjusted Operating Profit
Margin, Adjusted Earnings per Share, Adjusted Diluted Earnings per
Share, Adjusted Operating Profit after Tax Attributable to Common
Equity and Return on Adjusted Operating Profit after Tax
Attributable to Common Equity. These non-IFRS financial measures
are presented for supplemental informational purposes only and
should not be considered a substitute for profit after tax, profit
margin, return on equity or any other financial information
presented in accordance with IFRS and may be different from
similarly titled non-IFRS measures used by other companies.
We anticipate that full year Adjusted Operating Profit will be
approximately $280m to $290m and that our Reported Profit Before
Tax for 2024 will be approximately $257m to $267m. The adjustments
to full year Reported Profit Before Tax guidance as reflected
in full year Adjusted Operating Profit guidance are: $2.6
million for amortisation of acquired brands and customer lists,
$2.4 million of activities related to shareholders, $2.2 million of
employer tax on vesting of the growth shares, $2.4 million of owner
fees, $8.3 million of IPO preparation costs, and $2.3 million of
fair value of the cash settlement option on the growth shares, each
of which was incurred in H1 2024 as shown under 'Reconciliation of
Non-IFRS Financial Measures and Key Performance Indicators'.
In addition, our Adjusted Operating Profit guidance reflects an
estimated $2.6 million related to the amortisation of acquired
brands and customer lists expected to be incurred in H2 2024.
Neither the Group’s independent auditors, nor any other
independent accountants, have compiled, examined, or performed any
procedures with respect to the anticipated full year results
contained herein, nor have they expressed any opinion or any other
form of assurance on such information or its achievability, and
assume no responsibility for, and disclaim any association with,
the anticipated full year results.
Adjusted Operating Profit
We define Adjusted Operating Profit as Profit after Tax adjusted
for (i) goodwill impairment charges, (ii) acquisition costs, (iii)
bargain purchase gains, (iv) owner fees, (v) amortisation of
acquired brands and customer lists, (vi) activities in relation to
shareholders (vii) employer tax on vesting of the growth shares
(viii) initial public offering, (“IPO”) preparation costs and (ix)
fair value of the cash settlement option on the growth shares.
Items (i) to (ix) are refer to as 'Adjusting Items'. Adjusted
Operating Profit is the primary measure used by our management to
evaluate and understand our underlying operations and business
trends, forecast future results and determine future capital
investment allocations. Adjusted Operating Profit is the measure
used by our Executive Board to assess the financial performance of
our business in relation to our trading performance. The most
directly comparable IFRS measure is Profit after Tax. We believe
Adjusted Operating Profit is a useful measure as it allows
management to monitor our ongoing core operations and provides
useful information to investors and analysts regarding the net
results of the business. The core operations represent the primary
trading operations of the business.
Adjusted Operating Profit Margin
We define Adjusted Operating Profit Margin as Adjusted Operating
Profit (as defined above) divided by revenue. We believe that
Adjusted Operating Profit Margin is a useful measure as it allows
management to assess the profitability of our business in relation
to revenue. The most directly comparable IFRS measure is profit
margin, which is Profit after Tax divided by revenue.
Adjusted Operating Profit after Tax Attributable to
Common Equity
We define Adjusted Operating Profit after Tax Attributable to
Common Equity as Adjusted Operating Profit adjusting for (i) the
tax effect of the adjusting items to calculate Adjusted Operating
Profit and the tax effect from the coupons on the Additional Tier
1 ('AT1') capital. We define common equity as being the equity
belonging to the holder of the Group’s share capital. We believe
Adjusted Operating Profit after Tax Attributable to Common Equity
is a useful measure as it allows management to assess the
profitability of the equity belonging to the holder of the Group’s
share capital. The most directly comparable IFRS measure is Profit
after Tax.
Return on Adjusted Operating Profit after Tax
Attributable to Common Equity
We define the Return on Adjusted Operating Profit after Tax
Attributable to Common Equity as the Adjusted Operating Profit
after Tax divided by the average common equity for the period.
Common equity is defined as being the equity belonging to the
holder of the Group's share capital. Common equity is calculated as
the total equity after deducting for the Additional Tier 1 capital,
and is calculated as a two point average from the beginning of the
period to the end of the period. We believe Adjusted Operating
Profit after Tax Attributable to Common Equity is a useful measure
as it allows management to assess the return on the equity
belonging to the holder of the Group’s share capital. The most
directly comparable IFRS measure for Return on Adjusted Operating
Profit after Tax Attributable to Common Equity is Return on Equity
which is Reported Profit after Tax divided by the total equity.
Adjusted Earnings per Share
Adjusted Earnings per Share is defined as the Adjusted Operating
Profit after Tax Attributable to Common Equity as at the reporting
date over the total number of shares outstanding after deducting
for Own Shares. We believe Adjusted Earnings per Share is useful
measure as it allows management to assess the profitability of our
business per share. The most directly comparable IFRS metric is
Basic Earnings per Share. This metric has been designed to
highlight the operating earnings over the available share capital
of the Group. Dilution is calculated in the same way as it has been
for Diluted Earnings per Share. The most directly comparable IFRS
metric is Diluted Earnings per Share.
We believe that these non-IFRS financial measures provide useful
information to both management and investors by excluding certain
items that management believes are not indicative of our ongoing
operations. Our management uses these non-IFRS measures to evaluate
our business strategies and to facilitate operating performance
comparisons from period to period. We believe that these non-IFRS
measures provide useful information to investors because they
improve the comparability of our financial results between periods
and provide for greater transparency of key measures used to
evaluate our performance. In addition these non-IFRS measures are
frequently used by securities analysts, investors and other
interested parties in their evaluation of companies comparable to
us, many of which present related performance measures when
reporting their results.
These non-IFRS measures are used by different companies for
differing purposes and are often calculated in different ways that
reflect the circumstances of those companies. In addition, certain
judgments and estimates are inherent in our process to
calculate such non-IFRS measures. You should exercise caution in
comparing these non-IFRS measures as reported by other
companies.
These non-IFRS measures have limitations as analytical tools,
and you should not consider them in isolation or as substitutes for
analysis of our results as reported under IFRS. Some of these
limitations are:
- they do not reflect costs incurred
in relation to the acquisitions that we have undertaken;
- they do not reflect impairment of
goodwill;
- other companies in our industry may
calculate these measures differently than we do, limiting their
usefulness as comparative measures; and
- the adjustments made in calculating
these non-IFRS measures are those that management considers to be
not representative of our core operations and, therefore, are
subjective in nature.
Accordingly, prospective investors should not place undue
reliance on these non-IFRS measures.
We also use key performance indicators (“KPIs”) such as Average
Balances, Trades Executed, and Contracts Cleared to assess the
performance of our business and believe that these KPIs provide
useful information to both management and investors by showing the
growth of our business across the periods presented.
Our management uses these KPIs to evaluate our business
strategies and to facilitate operating performance comparisons from
period to period. We define certain terms used in this release as
follows:
“Average Balances” means the average amount of segregated and
non-segregated client balances that generate interest income for us
over a given period, calculated by taking the balances at the end
of each quarter for the last five quarters.
“Trades Executed” means the total number of trades executed on
our platform in a given year.
“Contracts Cleared” means the total number of contracts cleared
in a given year.
"Market Volumes" are calculated as follows:
- All volumes traded on Marex
key exchanges (CBOT, CME, Eurex, Euronext, ICE, LME, NYMEX
COMEX, SGX)
- Energy volumes on CBOT, Eurex,
ICE, NYMEX, SGX
- Financial securities (corporate
bonds, equities, FX, repo, volatility) on CBOE, CBOT, CME,
Eurex, Euronext, ICE, SGX
- Metals, agriculture and energy
volumes on CBOT, CME, Eurex, Euronext, ICE, LME, NYMEX COMEX,
SGX
Reconciliation of Non-IFRS Financial Measures and Key
Performance Indicators:
|
3 months ended 30 June 2024 |
|
3 months ended 31 March 2024 |
|
6 months ended 30 June 2024 |
|
6 months ended 30 June 2023 |
|
$m |
|
$m |
|
$m |
|
$m |
Profit After Tax |
59.3 |
|
43.6 |
|
102.9 |
|
80.8 |
Taxation charge |
20.8 |
|
15.3 |
|
36.1 |
|
28.7 |
Profit Before Tax |
80.1 |
|
58.9 |
|
139.0 |
|
109.5 |
Goodwill impairment charge1 |
— |
|
— |
|
— |
|
10.7 |
Bargain purchase gains2 |
— |
|
— |
|
— |
|
(0.3) |
Acquisition costs3 |
(0.2) |
|
0.2 |
|
— |
|
0.5 |
Amortisation of acquired brands and customer lists4 |
1.8 |
|
0.8 |
|
2.6 |
|
0.8 |
Activities relating to shareholders5 |
— |
|
2.4 |
|
2.4 |
|
— |
Employer tax on vesting of the growth shares6 |
2.2 |
|
— |
|
2.2 |
|
— |
Owner fees7 |
0.7 |
|
1.7 |
|
2.4 |
|
3.3 |
IPO preparation costs8 |
4.6 |
|
3.7 |
|
8.3 |
|
— |
Fair value of the cash settlement option on the growth shares9 |
2.3 |
|
— |
|
2.3 |
|
— |
Adjusted Operating Profit |
91.5 |
|
67.7 |
|
159.2 |
|
124.5 |
Adjusted Operating Tax10 |
(22.3) |
|
(16.3) |
|
(38.6) |
|
(29.5) |
Adjusted Operating Profit after Tax |
69.2 |
|
51.4 |
|
120.6 |
|
95.0 |
Profit attributable to AT1 note holders11 |
(2.4) |
|
(2.5) |
|
(4.9) |
|
(4.9) |
Adjusted Operating Profit after Tax Attributable to Common
Equity |
66.8 |
|
48.9 |
|
115.7 |
|
90.1 |
|
|
|
|
|
|
|
|
Adjusted Operating
Profit Margin12 |
22% |
|
19% |
|
20% |
|
20% |
|
|
|
|
|
|
|
|
Adjusted Earnings per
Share($)13 |
0.96 |
|
0.74 |
|
1.70 |
|
1.37 |
Adjusted Diluted
Earnings per Share ($)14 |
0.90 |
|
0.69 |
|
1.59 |
|
1.29 |
|
|
|
|
|
|
|
|
Common
Equity15 |
729.2 |
|
676.0 |
|
731.5 |
|
603.9 |
Return on Adjusted Operating Profit after Tax Attributable
to Common Equity (%) |
37% |
|
29% |
|
32% |
|
30% |
1. Goodwill impairment charges in 2023 relates to the impairment
recognised for goodwill relating to the Volatility Performance Fund
S.A. CGU (‘VPF’) largely due to declining projected revenue.
2. A bargain purchase gain was recognised as a result of the
ED&F Man Capital Markets division acquisition.
3. Acquisition costs are costs, such as legal fees incurred in
relation to the business acquisitions of ED&F Man Capital
Markets business, the OTCex group and Cowen's Prime Services and
Outsourced Trading business.
4. This represents the amortisation charge for the year/period
of acquired brands and customers lists.
5. Activities in relation to shareholders primarily consist of
dividend-like contributions made to participants within certain of
our share-based payments schemes. In prior years, this balance was
presented as part of amortisation of acquired brands and customer
lists.
6. Employer tax on vesting of the growth shares represents the
Group's tax charge arising from the vesting of the growth
shares.
7. Owner fees relate to management services to parties
associated with the former ultimate controlling party based on a
percentage of the Group’s profitability. Owner fees are excluded
from operating expenses as they do not form part of the operation
of the business and ceased to be incurred after the completion of
our offering.
8. IPO preparation costs related to consulting, legal and audit
fees, presented in the income statement within other expenses.
9. Fair value of the cash settlement option on the growth shares
represents the fair value liability of the growth shares at $2.3m.
Subsequent to the initial public offering when the holders of the
growth shares elected to take equity, the liability was
derecognised.
10. Adjusting Operating Tax represents the tax effect on the
Group's non-operating adjusting items.
11. Profit attributable to Additional Tier 1 (AT1) note holders
includes the coupons on the AT1 which are accounted for as
dividends and the tax benefit of the coupons.
12. Adjusted Operating Profit Margin is calculated by dividing
Adjusted Operating Profit (as defined above) divided by revenue for
the period.
13. The weighted average numbers of shares used in the
calculation for the six months ended 30 June 2024 and the six
months ended 30 June 2023 are disclosed in note 16. The weighted
average number of shares for Q1 2024 and Q2 2024 was 65,683,374 and
69,349,518 respectively.
14. The weighted average numbers of diluted shares used in the
calculation for H1 2024 and H1 2023 are disclosed in note 16. The
weighted average number of shares for Q1 2024 and Q2 2024 was
70,383,309 and 74,083,017 respectively.
15. Common equity is calculated as per the below:
|
3 months ended 30 June 2024 |
|
3 months ended 31 March 2024 |
|
6 months ended 30 June 2024 |
|
6 months ended 30 June 2023 |
|
$m |
|
$m |
|
$m |
|
$m |
Current period |
|
|
|
|
|
|
|
Equity |
882.3 |
|
771.3 |
|
882.3 |
|
725.2 |
Additional Tier 1 capital |
(97.6) |
|
(97.6) |
|
(97.6) |
|
(97.6) |
Common Equity |
784.7 |
|
673.7 |
|
784.7 |
|
627.6 |
|
|
|
|
|
|
|
|
Prior period |
|
|
|
|
|
|
|
Equity |
771.3 |
|
775.9 |
|
775.9 |
|
677.7 |
Additional Tier 1 capital |
(97.6) |
|
(97.6) |
|
(97.6) |
|
(97.6) |
Common Equity |
673.7 |
|
678.3 |
|
678.3 |
|
580.1 |
|
|
|
|
|
|
|
|
Common Equity (average of current and prior
periods) |
729.2 |
|
676.0 |
|
731.5 |
|
603.9 |
Reconciliation of costs included in summary
financial results to costs included in the unaudited condensed
consolidated income statement:
|
3 months ended 30 June 2024 |
|
3 months ended 31 March 2024 |
|
|
6 months ended 30 June 2024 |
|
6 months ended 30 June 2023 |
|
$m |
|
$m |
|
|
$m |
|
$m |
|
|
|
|
|
|
|
|
|
Front office costs1 |
(224.8) |
|
(210.1) |
|
|
(434.9) |
|
(335.2) |
Control and support
costs1 |
(100.4) |
|
(80.6) |
|
|
(181.0) |
|
(146.3) |
Adjusting items1 |
(11.4) |
|
(8.8) |
|
|
(20.2) |
|
(15.0) |
|
(336.6) |
|
(299.5) |
|
|
(636.1) |
|
(496.5) |
|
|
|
|
|
|
|
|
|
Compensation and benefits |
(256.0) |
|
(229.9) |
|
|
(485.9) |
|
(379.2) |
Other expenses |
(80.6) |
|
(69.6) |
|
|
(150.2) |
|
(106.6) |
Impairment of goodwill |
— |
|
— |
|
|
— |
|
(10.7) |
|
(336.6) |
|
(299.5) |
|
|
(636.1) |
|
(496.5) |
1. The above costs are not considered to be Non-IFRS measures
but purely a reconciliation of the costs categories that are
presented differently in the Adjusted Operating Profit calculation
to the same costs included in the Reported Profit in the income
statement.
Condensed
ConsolidatedFinancialStatements
Condensed Consolidated Financial Statements |
|
Unaudited Condensed Consolidated Income Statement |
18 |
Unaudited Condensed Consolidated Statement of Comprehensive
Income |
19 |
Unaudited Condensed Consolidated Statement of Financial
Position |
20 |
Unaudited Condensed Consolidated Statement of the Changes in
Equity |
22 |
Unaudited Condensed Consolidated Statement of Cash Flows |
23 |
Notes to the Unaudited Condensed Consolidated
Financial Statements |
25 |
Unaudited Condensed Consolidated Income
Statement For the six months ended
30 June
|
|
Six months ended |
|
Six months ended |
|
|
30 June 2024 |
|
30 June 2023 |
|
|
|
|
Restated1 |
|
Notes |
$m |
|
$m |
Commission and fee income |
4 |
801.9 |
|
687.8 |
Commission and fee expense |
4 |
(374.6) |
|
(340.6) |
Net commission income |
4 |
427.3 |
|
347.2 |
Net trading income |
4 |
242.7 |
|
212.5 |
Interest income |
4 |
353.6 |
|
308.3 |
Interest expense |
4 |
(252.6) |
|
(248.3) |
Net interest income |
4 |
101.0 |
|
60.0 |
Net physical commodities income |
4 |
16.9 |
|
2.7 |
Revenue |
4 |
787.9 |
|
622.4 |
|
|
|
|
|
Expenses: |
|
|
|
|
Compensation and benefits |
18 |
(485.9) |
|
(379.2) |
Depreciation and amortisation |
|
(15.5) |
|
(14.9) |
Other expenses |
|
(150.2) |
|
(106.6) |
Impairment of goodwill |
8 |
— |
|
(10.7) |
Recovery/(provision) for credit losses |
|
2.2 |
|
(4.5) |
Bargain purchase gain on
acquisitions |
|
— |
|
0.3 |
Other income |
|
0.5 |
|
1.9 |
Share
of results in associates and joint ventures |
|
— |
|
0.8 |
Profit before tax |
|
139.0 |
|
109.5 |
Tax |
5 |
(36.1) |
|
(28.7) |
Profit after tax |
|
102.9 |
|
80.8 |
|
|
|
|
|
Attributable
to: |
|
|
|
|
Ordinary shareholders of the
Company |
|
96.3 |
|
74.2 |
Other
equity holders2 |
|
6.6 |
|
6.6 |
|
|
|
|
|
Earnings per
share3 |
|
|
|
|
Basic (dollars per share) |
16 |
1.41 |
|
1.13 |
Diluted
(dollars per share) |
16 |
1.32 |
|
1.06 |
1. Prior period comparatives have been restated. Refer to note
2(c) for further information.
2. Other equity holders relate to holders of AT1 securities.
3. Earnings per share has been restated due to the reverse share
split, refer to note 16 for further information.
Unaudited Condensed Consolidated Statement of
Comprehensive IncomeFor the six months ended
30 June
|
|
Six months ended |
|
Six months ended |
|
|
30 June 2024 |
|
30 June 2023 |
|
|
|
|
Restated1 |
|
|
$m |
|
$m |
Profit after tax |
|
102.9 |
|
80.8 |
Other comprehensive
income |
|
|
|
|
Items that may be
reclassified subsequently to profit and loss: |
|
|
|
|
(Loss)/gain on cash flow hedge
reserve |
|
(5.7) |
|
3.6 |
Deferred tax on cash flow
hedge reserve |
|
1.4 |
|
— |
Currency translation
adjustments |
|
(1.4) |
|
— |
Items that will not be
recycled to profit and loss: |
|
|
|
|
Change in fair value of
financial liabilities designated at FVTPLdue to own credit
risk |
|
(3.4) |
|
(8.7) |
Deferred tax on change in fair
value of financial liabilities designated at FVTPL due to own
credit risk |
|
0.8 |
|
— |
Gain / (loss) on revaluation
of investments |
|
1.2 |
|
(0.3) |
Deferred tax on revaluation of
investments |
|
(0.3) |
|
(0.1) |
Deferred tax on share-based
payments |
|
2.5 |
|
— |
Current
tax on share-based payments |
|
0.9 |
|
— |
Other comprehensive loss net of tax |
|
(4.0) |
|
(5.5) |
Total comprehensive income |
|
98.9 |
|
75.3 |
|
|
|
|
|
Attributable
to: |
|
|
|
|
Ordinary shareholders of the
Company |
|
92.3 |
|
68.7 |
Other
equity holders |
|
6.6 |
|
6.6 |
1. Prior period comparatives have been restated to align to the
figures presented in the Statement of Changes in Equity.
Unaudited Condensed Consolidated Statement of Financial
PositionAs at 30 June and 31
December
|
|
30 June 2024 |
|
31 December 2023 |
|
|
|
|
Restated1 |
|
Notes |
$m |
|
$m |
Assets |
|
|
|
|
Non-current
assets |
|
|
|
|
Goodwill |
8 |
167.4 |
|
163.6 |
Intangible assets |
|
53.7 |
|
56.0 |
Property, plant and
equipment |
|
18.4 |
|
16.6 |
Right-of-use asset |
13 |
60.6 |
|
40.6 |
Investments |
|
17.5 |
|
16.2 |
Deferred tax |
|
20.7 |
|
21.4 |
Treasury instruments
(unpledged) |
|
— |
|
60.8 |
Treasury instruments (pledged as collateral) |
|
185.9 |
|
300.4 |
Total non-current assets |
|
524.2 |
|
675.6 |
|
|
|
|
|
Current
assets |
|
|
|
|
Corporate income tax
receivable |
|
2.3 |
|
0.1 |
Trade and other
receivables |
9 |
4,413.5 |
|
4,789.8 |
Inventory |
|
123.0 |
|
163.4 |
Equity instruments
(unpledged) |
|
391.7 |
|
189.6 |
Equity instruments (pledged as
collateral) |
|
2,154.8 |
|
1,331.7 |
Derivative instruments |
10 |
730.8 |
|
655.6 |
Stock borrowing |
|
1,795.5 |
|
2,501.4 |
Treasury instruments
(unpledged) |
|
345.4 |
|
558.5 |
Treasury instruments (pledged
as collateral) |
|
2,689.7 |
|
2,062.6 |
Reverse repurchase
agreements |
|
2,104.3 |
|
3,199.8 |
Cash
and cash equivalents |
|
1,914.2 |
|
1,483.5 |
Total current assets |
|
16,665.2 |
|
16,936.0 |
Total assets |
|
17,189.4 |
|
17,611.6 |
1. Certain prior period comparatives have been restated. Refer
to note 2(c) for further information.
|
|
30 June 2024 |
|
31 December 2023 |
|
|
|
|
Restated1 |
|
Notes |
$m |
|
$m |
Liabilities |
|
|
|
|
Current
liabilities |
|
|
|
|
Repurchase agreements |
|
1,844.4 |
|
3,118.9 |
Trade and other payables |
11 |
7,128.6 |
|
6,785.9 |
Stock lending |
|
2,563.1 |
|
2,323.3 |
Short securities |
|
1,736.6 |
|
1,924.8 |
Lease liability |
13 |
13.0 |
|
13.2 |
Derivative instruments |
10 |
496.8 |
|
402.2 |
Corporation tax |
|
9.4 |
|
7.6 |
Debt securities |
|
1,474.9 |
|
1,308.4 |
Provisions |
|
0.5 |
|
0.4 |
Total current liabilities |
|
15,267.3 |
|
15,884.7 |
Non-current
liabilities |
|
|
|
|
Lease liability |
13 |
65.4 |
|
39.4 |
Debt securities |
|
971.4 |
|
907.9 |
Deferred tax liability |
|
3.0 |
|
3.7 |
Total non-current liabilities |
|
1,039.8 |
|
951.0 |
Total liabilities |
|
16,307.1 |
|
16,835.7 |
Total net assets |
|
882.3 |
|
775.9 |
|
|
|
|
|
Equity |
|
|
|
|
Share capital |
12 |
0.1 |
|
0.1 |
Share premium |
|
202.6 |
|
134.3 |
Additional Tier 1 capital
(AT1) |
|
97.6 |
|
97.6 |
Retained earnings |
|
611.2 |
|
555.3 |
Own shares |
|
(23.2) |
|
(9.8) |
Other
reserves |
|
(6.0) |
|
(1.6) |
Total equity |
|
882.3 |
|
775.9 |
1. Certain prior period comparatives have been restated. Refer
to note 2(c) for further information.
Unaudited Condensed Consolidated Statement of the
Changes in Equityand Movements in
ReservesFor the six months ended
30 June
|
Sharecapital |
Sharepremium |
Additional (AT1) capital |
Retainedearnings |
Own shares |
Other reserves |
Total |
|
$m |
$m |
$m |
$m |
$m |
$m |
$m |
|
|
|
|
|
|
|
|
At 1
January 2023 |
0.1 |
134.3 |
97.6 |
455.3 |
(7.9) |
(1.7) |
677.7 |
Profit after tax for the period |
— |
— |
6.6 |
74.2 |
— |
— |
80.8 |
Gain on cash flow hedge |
— |
— |
— |
— |
— |
3.6 |
3.6 |
Change in fair value due to
own credit risk |
— |
— |
— |
— |
— |
(8.7) |
(8.7) |
Loss on revaluation of
investments |
— |
— |
— |
— |
— |
(0.3) |
(0.3) |
Deferred tax on revaluation of investments |
— |
— |
— |
— |
— |
(0.1) |
(0.1) |
Total comprehensive income for the period |
— |
— |
6.6 |
74.2 |
— |
(5.5) |
75.3 |
AT1 dividends paid |
— |
— |
(6.6) |
— |
— |
— |
(6.6) |
Ordinary dividends paid |
— |
— |
— |
(24.5) |
— |
— |
(24.5) |
Repurchase of own shares |
— |
— |
— |
— |
(4.2) |
— |
(4.2) |
Share-based payments |
— |
— |
— |
7.1 |
— |
— |
7.1 |
Other
movements |
— |
— |
— |
0.3 |
— |
0.1 |
0.4 |
At 30 June 2023 |
0.1 |
134.3 |
97.6 |
512.4 |
(12.1) |
(7.1) |
725.2 |
|
|
|
|
|
|
|
|
At 1 January
2024 |
0.1 |
134.3 |
97.6 |
555.3 |
(9.8) |
(1.6) |
775.9 |
Profit after tax for the
period |
— |
— |
6.6 |
96.3 |
— |
— |
102.9 |
Loss on cash flow hedge |
— |
— |
— |
— |
— |
(5.7) |
(5.7) |
Deferred tax on cash flow
hedge |
— |
— |
— |
— |
— |
1.4 |
1.4 |
Change in fair value due to
own credit risk |
— |
— |
— |
— |
— |
(3.4) |
(3.4) |
Deferred tax on change in fair
value of financial liabilities designated at FVTPL due to own
credit risk |
— |
— |
— |
— |
— |
0.8 |
0.8 |
Gain on revaluation of
investments |
— |
— |
— |
— |
— |
1.2 |
1.2 |
Deferred tax on revaluation of
investments |
— |
— |
— |
— |
— |
(0.3) |
(0.3) |
Deferred tax on share-based
payments |
— |
— |
— |
— |
— |
2.5 |
2.5 |
Current tax on share-based
payments |
— |
— |
— |
— |
— |
0.9 |
0.9 |
Currency translation adjustments |
— |
— |
— |
— |
— |
(1.4) |
(1.4) |
Total comprehensive income for the period |
— |
— |
6.6 |
96.3 |
— |
(4.0) |
98.9 |
AT1 dividends paid |
— |
— |
(6.6) |
— |
— |
— |
(6.6) |
Ordinary dividends paid |
— |
— |
— |
(44.1) |
— |
— |
(44.1) |
Share premium |
— |
68.3 |
— |
— |
— |
— |
68.3 |
Repurchase of own shares |
— |
— |
— |
— |
(19.8) |
— |
(19.8) |
Fair value of the cash
settlement option on the growth shares |
— |
— |
— |
2.3 |
— |
— |
2.3 |
Share-based payments |
— |
— |
— |
7.4 |
— |
— |
7.4 |
Share settlement of
share-based awards |
— |
— |
— |
(6.4) |
6.4 |
— |
— |
Other
movements |
— |
— |
— |
0.4 |
— |
(0.4) |
— |
At 30 June 2024 |
0.1 |
202.6 |
97.6 |
611.2 |
(23.2) |
(6.0) |
882.3 |
Unaudited Condensed Consolidated Statement of Cash
FlowsFor the six months ended
30 June
|
|
Six months ended |
|
Six months ended |
|
|
30 June 2024 |
|
30 June 2023 |
|
Notes |
$m |
|
$m |
Profit before tax |
|
139.0 |
|
109.5 |
Adjustments
for: |
|
|
|
|
Amortisation of intangible
assets |
|
6.5 |
|
2.9 |
Depreciation of property,
plant and equipment |
|
3.5 |
|
2.1 |
Depreciation of right-of-use
asset |
|
5.4 |
|
4.8 |
Impairment of right-of-use
asset |
|
0.1 |
|
5.1 |
Gain on sale of
subsidiary |
7 |
(2.5) |
|
— |
Impairment of goodwill |
8 |
— |
|
10.7 |
Bargain purchase gain on
acquisitions |
|
— |
|
(0.3) |
Increase / (decrease) in
provisions |
|
0.1 |
|
(1.2) |
Provision for credit
losses |
|
(2.2) |
|
4.5 |
Share of results in associates
and joint ventures |
|
— |
|
(0.8) |
Lease liability foreign
exchange revaluation |
13 |
(0.2) |
|
(0.4) |
Movement in fair value of
derivative instruments |
10 |
19.4 |
|
(3.7) |
Other revaluations |
|
6.0 |
|
(4.6) |
Other non-cash movements |
|
(4.5) |
|
4.8 |
Fair value of the cash
settlement option on the growth shares |
|
2.3 |
|
— |
Share-based compensation expense |
|
7.4 |
|
7.1 |
Operating cash flow before changes in working
capital |
|
180.3 |
|
140.5 |
Working capital
adjustments: |
|
|
|
|
Decrease / (increase) in trade
and other receivables |
|
380.4 |
|
(14.8) |
Increase / (decrease) in trade
and other payables |
|
341.9 |
|
(129.2) |
(Increase) / decrease in
treasury instruments |
|
(238.7) |
|
432.0 |
(Increase) / decrease in
equity instruments |
|
(1,213.4) |
|
655.1 |
Increase in debt
securities |
|
226.6 |
|
754.6 |
Net repayment of
borrowings |
|
— |
|
(148.7) |
Decrease / (increase) in
inventory |
|
40.4 |
|
(6.6) |
Decrease in net repurchase
agreements |
|
(179.0) |
|
(102.0) |
Increase / (decrease) in net stock borrowing and lending |
|
945.7 |
|
(735.1) |
Cash inflow from operating activities |
|
484.2 |
|
845.8 |
Corporation tax paid |
|
(31.7) |
|
(39.9) |
Net cash inflow from operating activities |
|
452.5 |
|
805.9 |
For the six months ended 30 June 2024, interest received was
$348.3m (six months ended 30 June 2023: $320.3m), interest paid was
$238.6m (six months ended 30 June 2023: $262.2m) and dividends
received were $nil (six months ended 30 June 2023: $nil).
|
|
Six months ended |
|
Six months ended |
|
|
30 June 2024 |
|
30 June 2023 |
|
Notes |
$m |
|
$m |
Investing activities |
|
|
|
|
Redemption of investment in
associate |
|
— |
|
6.4 |
Acquisition of businesses, net of
cash acquired |
7 |
(4.0) |
|
(29.5) |
Net proceeds from sale of
subsidiary |
7 |
2.5 |
|
— |
Payment of contingent
consideration |
|
— |
|
(1.6) |
Purchase of intangible
assets |
|
(3.9) |
|
(1.6) |
Purchase of property, plant and equipment |
|
(5.3) |
|
(2.7) |
Net cash from investing activities |
|
(10.7) |
|
(29.0) |
|
|
|
|
|
Financing
activities |
|
|
|
|
Proceeds from issuance of
ordinary shares1 |
12 |
73.0 |
|
— |
Issuance costs of ordinary
shares |
12 |
(4.7) |
|
— |
Purchase of own shares |
|
(19.8) |
|
(4.2) |
Dividends paid |
6 |
(50.7) |
|
(31.1) |
Payment of lease liabilities |
|
(1.6) |
|
(4.4) |
Net cash used in financing activities |
|
(3.8) |
|
(39.7) |
Net increase in cash and cash equivalents |
|
438.0 |
|
737.2 |
|
|
|
|
|
Cash and cash
equivalents |
|
|
|
|
Cash and cash equivalents at 1
January |
|
1,483.5 |
|
910.1 |
Increase in cash |
|
438.0 |
|
737.2 |
Effect of foreign exchange rate changes |
|
(7.3) |
|
5.0 |
Cash and cash equivalents at 30 June |
|
1,914.2 |
|
1,652.3 |
1. The net proceeds of $68.3m from issuance of ordinary shares
is described in note 12.
Notes to the Unaudited Condensed Consolidated Financial
Statements
1 General Information
Marex Group plc (the 'Group' and ‘Company’) is incorporated in
England and Wales under the Companies Act. The address of the
registered office is 155 Bishopsgate, London, EC2M 3TQ, United
Kingdom. The principal activities of the Group and the nature of
the Group’s operations are set out in note 4.
The unaudited condensed consolidated financial statements of the
Group are presented in US dollars ('USD' or ‘$’), which is also the
Company’s functional currency. All amounts have been rounded to the
nearest tenth of a million (‘m’), except where otherwise
indicated.
The information for the year ended 31 December 2023 does not
constitute statutory accounts as defined in section 434 of the
Companies Act 2006. A copy of the statutory accounts for that year
has been delivered to the Registrar of Companies. The auditors
reported on those accounts: their report was unqualified, did not
draw attention to any matters by way of emphasis and did not
contain a statement under section 498(2) or (3) of the Companies
Act 2006.
On 24 April 2024, the Group's registration statement on Form F-1
related to its initial public offering (“IPO”) was declared
effective. On 25 April 2024, the Group’s ordinary shares began
trading on the Nasdaq Global Select Market under the symbol “MRX”.
On 29 April 2024, the Group completed its IPO, in which the Group
issued 3,846,153 new ordinary shares each at initial offering price
of $19.00 per ordinary share for gross proceeds to the Group of
$73.0m, before deducting issuance transaction costs of $4.7m. In
the IPO, selling shareholders sold a total of 13,028,951 existing
ordinary shares. The Group did not receive any proceeds from this
sale.
In connection with its IPO, the Group undertook a share capital
reorganisation involving the issuance and conversion of growth
shares and non-voting ordinary shares into ordinary shares, the
cancellation of deferred shares, the redenomination of the nominal
value of ordinary shares and a 1.88 to 1 reverse split of ordinary
shares. Further information is disclosed in note 12.
2 Material Accounting Policy Information
(a) Basis of preparation
The interim condensed consolidated financial statements as at 30
June 2024 and for the six months ended 30 June 2024 and 2023 have
been prepared in accordance with IAS 34 Interim Financial
Reporting. The Group has prepared the financial statements on the
basis that it will continue to operate as a going concern. The
Directors consider that there are no material uncertainties that
may cast significant doubt over this assumption. They have formed a
judgement that there is a reasonable expectation that the Group has
adequate resources to continue in operational
existence for the foreseeable future, and not less than 12
months from the end of the reporting period.
The interim condensed consolidated financial statements do not
include all the information and disclosures required in the annual
financial statements, and should be read in conjunction with the
2023 Group Annual Report (the 2023 Group Annual Report refers to
the consolidated statements of financial position of Marex Group
plc and subsidiaries as at 31 December 2023 and 2022, the related
consolidated income statements, statements of comprehensive income,
changes in equity, and cash flows).
(b) New standards, interpretations and amendments
adopted by the Group
The accounting policies adopted in the preparation of the
interim condensed consolidated financial statements are consistent
with those followed in the preparation of the 2023 Group Annual
Report, except for the adoption of new standards effective as of 1
January 2024. The Group has not early adopted any standard,
interpretation or amendment that has been issued but is not yet
effective.
Several amendments apply for the first time in 2024, but do not
have any impact on the interim condensed consolidated financial
statements of the Group.
Supplier Finance Arrangements – Amendments to IAS 7 and
IFRS 9
In May 2023, the IASB issued amendments to IAS 7 Statement of
Cash Flows and IFRS 9 Financial Instruments: Disclosures to clarify
the characteristics of supplier finance arrangements and require
additional disclosure of such arrangements. The disclosure
requirements in the amendments are intended to assist users of
financial statements in understanding the effects of supplier
finance arrangements on an entity’s liabilities, cash flows and
exposure to liquidity risk.
The transition rules clarify that an entity is not required to
provide the disclosures in any interim periods in the year of
initial application of the amendments. Thus, the amendments had no
impact on the Group’s interim condensed consolidated financial
statements.
Amendments to IFRS 16: Lease Liability in a Sale and
Leaseback
In September 2022, the IASB issued amendments to IFRS 16 to
specify the requirements that a seller-lessee uses in measuring the
lease liability arising in a sale and leaseback transaction, to
ensure the seller-lessee does not recognise any amount of the gain
or loss that relates to the right of use it retains.
The amendments had no impact on the Group’s interim condensed
consolidated financial statements.
Amendments to IAS 1: Presentation of Financial
Statements – Non-current Liabilities with Covenants
In October 2022, the IASB issued amendments that specify that
only covenants that an entity is required to comply with on or
before the end of the reporting period affect the entity’s right to
defer settlement of a liability for at least 12 months after the
reporting date. Such covenants affect whether the right exists at
the end of the reporting period, even if compliance with the
covenant is assessed only after the reporting date.
The IASB specifies that the right to defer settlement of a
liability for at least 12 months after the reporting date is not
affected if an entity only has to comply with a covenant after the
reporting period. However if the entity’s right to defer settlement
of a liability is subject to the entity complying with covenants
within 12 months after the reporting period, an entity discloses
information that enables users of the financial statements to
understand the risk of the liabilities becoming repayable within 12
months after the reporting period. This includes information about
the covenants, the carrying amount of related liabilities and facts
and circumstances, if any, that indicate that the entity may have
difficulties complying with the covenants.
The amendments had no impact on the Group’s interim condensed
consolidated financial statements.
(c) Restatement
In these condensed consolidated financial statements we are
restating the condensed consolidated income statement for the six
months ended 30 June 2023 to align its presentation to the
consolidated income statement for the year ended 31 December 2023
following the voluntary changes in presentation adopted by the
Group during 2023 and correct certain errors, in accordance with
International Accounting Standard 8, Accounting policies, changes
in accounting estimates and correction of errors.
Changes in accounting policies
Change of presentation of the condensed consolidated
income statement
The Group presented revenue and expenses in its condensed
consolidated income statement for the six months ended 30 June 2023
at an aggregated level. During 2023, the Group decided to present
within revenue all the income derived from the ordinary activities
of the Group and disaggregate them in the income statement. In
connection with this, commissions and fees paid to exchanges and
clearing houses and all interest income and interest expense
incurred as part of the ordinary activities of the Group, are now
presented within revenue. Similarly, a more granular presentation
was adopted for the Group’s expenses. This change has been applied
retrospectively for the six months ended 30 June 2023 for
comparative purposes and only impacts the presentation of the
condensed consolidated income statement and has no impact on profit
after tax. The changes do not impact the condensed consolidated
statements of other comprehensive income and changes in equity.
Presentation of income from physical commodities
trading
For the six months ended 30 June 2023, the Group retrospectively
adopted a voluntary change in accounting policy, with respect to
the presentation of revenue and associated costs from the sale of
physical commodities, which in previous issued interim financial
statements were presented on a gross basis within revenue and
operating costs, respectively, in the condensed consolidated income
statement. To align the presentation in the income statement to the
manner in which the physical commodities trading business is
managed, the Group decided to change its accounting policy for all
revenue arising from fair valuing forward contracts to buy and sell
physical commodities to be presented on a net basis, with no gross
revenue and gross cost of sales presented upon physical settlement
of the forward contracts. This retrospective change in accounting
policy does not impact the condensed consolidated statements of
comprehensive income, of cash flows or changes in equity.
In aggregate, considering the above changes in accounting
policies in the income statement, revenue as restated for the six
months ended 30 June 2023 is $622.4m. Previously, revenue was
$1,191.3m. All other changes resulted in a disaggregation of line
items into a nature-based presentation to provide better
information or present them separately.
|
30 June 2023 |
|
$m |
Revenue as originally presented |
1,191.3 |
plus: interest income |
107.4 |
minus: interest expense |
(184.4) |
minus: commission and fee
expense |
(340.6) |
minus: cost of sales of physical commodities |
(151.3) |
Revenue as restated |
622.4 |
Correction of errors
Presentation of interest income calculated using the
effective interest method
The Group did not present separately in the condensed
consolidated income statement the interest income calculated using
the effective interest method as required by IAS 1. As restated,
interest income for the six months ended 30 June 2023 is $308.3m.
As reported, $200.9m of interest income was presented within
revenue and $107.4m as finance income. The error did not impact
profit after tax. The correction of this error does not impact the
condensed consolidated statements of comprehensive income, cash
flows or of changes in equity.
Presentation of impairment for credit
losses
The Group did not present separately in the condensed
consolidated income statement the impairment for credit losses as
required by IAS 1. As restated, provision for credit losses for the
six months ended 30 June 2023 is $4.5m and was previously presented
as part of operating expenses. The error did not impact profit
after tax. The correction of this error does not impact the
condensed consolidated statements of comprehensive income, cash
flows or of changes in equity.
Impairment of goodwill
The Group did not recognise an impairment charge related to
Volatility Performance Fund S.A. (“VPF”) as required by IAS 36,
Impairment of assets, in the six months ended 30 June 2023. As
restated, impairment of goodwill for the six months ended 30 June
2023 increased by $10.7m, and goodwill decreased by $10.7m.
Restatement of consolidated statement of financial
position as of 31 December 2023
Presentation of derivative instruments
During the preparation of the interim condensed consolidated
financial statements, the Group noted an error in the presentation
of derivative instruments on the statement of financial position as
at 31 December 2023. The Group presented certain legs of equity
options separately within derivative instruments assets and
derivative instruments liabilities; however they should have been
presented as one unit of account.
The Group evaluated the materiality of the misstatement in
accordance with Staff Accounting Bulletin (“SAB”) No. 99,
Materiality, and SAB No. 108, considering both qualitative and
quantitative factors. The Group determined the misstatement in the
consolidated financial position as at 31 December 2023 and 2022
included in the consolidated statement of financial position as at
31 December 2023 and 2022 in the 2023 Group Annual Report was
immaterial and did not require restatement of the previously issued
consolidated financial statements. The error did not impact the
consolidated income statements, statements of comprehensive income,
changes in equity, and cash flows included in the 2023 Group Annual
Report. The restatement is summarised in the table below.
|
As reported |
Adjustment |
As restated |
31 December 2023 |
$m |
$m |
$m |
Derivative instruments - assets |
794.1 |
(138.5) |
655.6 |
Total current assets |
17,074.5 |
(138.5) |
16,936.0 |
Total assets |
17,750.1 |
(138.5) |
17,611.6 |
Derivative instruments -
liabilities |
540.7 |
(138.5) |
402.2 |
Total current liabilities |
16,023.2 |
(138.5) |
15,884.7 |
Total liabilities |
16,974.2 |
(138.5) |
16,835.7 |
Presentation of Equity Instruments
The Group noted an error in the presentation of equity
instruments on the statement of financial position as at 31
December 2023. The Group should present certain equity
instruments that are pledged with the Options Clearing
Corporation (‘OCC’), and that can be repledged
by the OCC, separately from other unpledged equity instruments
in accordance with IFRS 9 Financial Instruments. As
restated, equity instruments (pledged as collateral) is $1,331.7m,
and equity instruments (unpledged) is $189.6m as at 31 December
2023. As reported, equity instruments were $1,521.3m. The Group
evaluated the materiality of the misstatement in accordance
with Staff Accounting Bulletin (“SAB”) No. 99, Materiality, and SAB
No. 108, considering both qualitative and quantitative factors. The
Group determined the misstatement in the consolidated statement of
financial position as at 31 December 2023 and 2022 included in
the consolidated financial statement as at 31 December 2023 and
2022 and for each of the years in the two years ended 31 December
2023 included in the 2023 Group Annual Report was immaterial and
did not required restatement of the previously issued
consolidated financial statements. The correction of
this error did not change the total assets and does not impact the
condensed consolidated income statement, statements of
comprehensive income, cash flows or of changes in equity.
3 Critical accounting judgements and key sources of
estimation uncertainty
In the application of the Group’s accounting policies, the
Directors are required to make judgements, estimates and
assumptions that affect the reported carrying amounts of assets,
liabilities, income and expenses. The estimates and associated
assumptions are based on historical experience and other factors
that are considered to be relevant and reasonable under the
circumstances.
Estimates and assumptions are reviewed on an ongoing basis and
revisions to accounting estimates are recognised in the period an
estimate is revised. The following critical accounting judgement
has been applied in the preparation of these interim condensed
consolidated financial statements:
Impairment of goodwill
As reported in the Group’s annual report and accounts for the
year ended 31 December 2023, the determination of whether goodwill
is impaired requires an estimation of the recoverable amount of the
cash generating unit to which goodwill has been allocated, which is
the higher of the value in use or the fair value less costs of
disposal. The value in use calculation requires the Group to
estimate the future revenues from the cash generating unit and a
suitable discount rate to calculate the present value. The key
sources of estimation uncertainty in the assessment of goodwill
impairment are the assumptions around the discount rates, revenue
growth and terminal growth rates and are spelled out in the Group’s
annual report and accounts for the year ended 31 December 2023.
Accounting for Growth Shares
The Group issued Growth Shares and Growth Share Options under
previous share-based payment awards which vest or become
exercisable on the occurrence of a liquidity event which was
satisfied by the IPO. The terms of the awards permitted the holders
to elect for cash or equity settlement, though in the absence of an
election, the default settlement was through the issuance of
non-voting ordinary shares. In accordance with IFRS 2 Share Based
Payments, as the choice of settlement method resided with the
holder, these awards were considered to be compound instruments.
Consequently, at the point of settlement the Group remeasured the
liability arising from the cash settlement option to its fair
value. As the awards were all settled in equity, the fair value of
the liability was transferred directly to equity, as the
consideration for the equity instruments issued.
The valuation of the liability was deemed a key source of
estimation uncertainty as the terms of the awards placed
restrictions on the amount of cash that Marex Group plc could
provide for settlement of the obligation which meant that there was
significant uncertainty as to the timing and amount of the cash
payments to holders. Key judgements and estimates include:
probability and impact of management actions that could have been
reasonably contemplated, the growth rate of the Group’s profit
which drives the potential Group dividend requirements; and the
discount rate applied to the cash flows.
These judgements and estimates significantly impact the
valuation of the growth shares and, consequently, the Group's
financial statements. The Group has recorded the fair value of the
liability related to growth shares at $2.3m.
Additional details and further explanations are provided in Note
12 to the interim condensed consolidated financial statements.
4 Segmental Analysis
Revenue
Revenues within the scope of IFRS 15 are presented as commission
and fee income in the income statement. Revenues that are not
within the scope of IFRS 15 are presented within net trading
income, net interest income and net physical commodities income in
the income statement. The disaggregation in this note shows the
revenue by each of the five operating segments. The substantial
majority of the Group's performance obligations for revenues from
contracts with clients is satisfied at a point in time. Revenue
recognised over time is not material.
Operating Segments
Operating segments information is presented in a manner
consistent with the internal reporting provided to the Chief
Operating Decision Maker (‘CODM’). The CODM, who is responsible for
allocating resources and assessing performance, has been identified
as the Group’s Executive Committee. The CODM regularly reviews the
Group’s operating results in order to assess performance and to
allocate resources. The accounting policies of the operating
segments are the same as the Group’s accounting policies.
Adjusted operating profit/(loss) is the segments performance
measure and excludes income and expenses that are not considered
directly related to the performance of our segments as detailed in
the reconciliation below.
For management purposes, the Group is organised into the
following operating segments, based on the services provided, as
follows:
- Clearing – The interface between
exchanges and clients. The Group provides the connectivity that
allows its clients access to exchanges and central clearing houses.
As clearing members, the Group acts as principal on behalf of its
clients and generates revenue on a commission per trade basis. The
Group provides clearing services across four principal markets:
metals, agricultural products, energy and financial securities
markets across different geographies.
- Agency and Execution – The Group
matches buyers and sellers on an agency basis by facilitating price
discovery primarily across energy and financial securities markets.
The Agency and Execution segment primarily generates revenue on a
commission per trade basis without material credit or market risk
exposure. In addition to listed products that trade directly on
exchanges, many of the Group’s markets are traded on an OTC
basis.
- Market Making – The Group acts as
principal to provide direct market pricing to professional and
wholesale counterparties, primarily metals, agriculture, energy and
financial securities markets. The Market Making segment primarily
generates revenue through charging a spread between buying and
selling prices, without taking significant proprietary risk. The
Market Making operations are diversified across geographies and
asset classes.
- Hedging and Investment Solutions –
The Group offers bespoke hedging and investment solutions to its
clients and generates revenue through a return built into the
product pricing. Tailored hedging solutions allow producers and
consumers of commodities to hedge their exposure to movements in
market prices, as well as exchange rates, across a variety of
different time horizons.
- The Corporate segment includes the
Group’s control and support functions: finance, treasury, IT, risk,
compliance, legal, human resources and executive management to
support the operating segments. Corporate manages the resources of
the Group, makes investment decisions and provides operational
support to the business segments. Corporate manages the Group’s
funding requirements, interest expense is incurred through debt
securities issuance, which is charged to other segments thorough
inter-segmental funding allocations to reflect their consumption of
these resources. Interest Income is derived from interest on
in-house cash balances. The adjusted operating loss includes the
expenses related to costs of the functions that are not recovered
from the operating segments and corporate costs.
Segment information for the six months ended 30 June 2024 |
Clearing |
|
Agency and Execution |
|
Market Making |
|
Hedging and Investment Solutions |
|
Corporate |
|
Total |
|
$m |
|
$m |
|
$m |
|
$m |
|
$m |
|
$m |
Commission and fee income |
474.6 |
|
320.8 |
|
6.5 |
|
— |
|
— |
|
801.9 |
Commission and fee expense |
(339.0) |
|
(26.3) |
|
(9.3) |
|
— |
|
— |
|
(374.6) |
Net commission income/(expense) |
135.6 |
|
294.5 |
|
(2.8) |
|
— |
|
— |
|
427.3 |
Net trading
income |
2.3 |
|
19.9 |
|
108.5 |
|
112.0 |
|
— |
|
242.7 |
Interest income/(expense) |
148.2 |
|
18.8 |
|
— |
|
— |
|
(66.0) |
|
101.0 |
Inter-segmental funding allocations2 |
(61.2) |
|
(1.3) |
|
(10.6) |
|
(26.0) |
|
99.1 |
|
— |
Net interest income/(expense) |
87.0 |
|
17.5 |
|
(10.6) |
|
(26.0) |
|
33.1 |
|
101.0 |
Net physical commodities income |
— |
|
0.7 |
|
16.2 |
|
— |
|
— |
|
16.9 |
Revenue |
224.9 |
|
332.6 |
|
111.3 |
|
86.0 |
|
33.1 |
|
787.9 |
Adjusted operating profit/(loss) |
119.0 |
|
44.9 |
|
39.5 |
|
26.0 |
|
(70.2) |
|
159.2 |
|
|
|
|
|
|
|
|
|
|
|
|
Other segment
information |
|
|
|
|
|
|
|
|
|
|
|
Depreciation and amortisation |
(0.2) |
|
(0.5) |
|
(0.2) |
|
(0.3) |
|
(14.3) |
|
(15.5) |
Segment information for the six months ended 30 June 2023
(restated)1 |
Clearing |
|
Agency and Execution |
|
Market Making |
|
Hedging and Investment Solutions |
|
Corporate |
|
Total |
|
$m |
|
$m |
|
$m |
|
$m |
|
$m |
|
$m |
Commission and fee income |
445.7 |
|
237.7 |
|
4.4 |
|
— |
|
— |
|
687.8 |
Commission and fee expense |
(321.6) |
|
(13.2) |
|
(5.8) |
|
— |
|
— |
|
(340.6) |
Net
commission income/(expense) |
124.1 |
|
224.5 |
|
(1.4) |
|
— |
|
— |
|
347.2 |
Net trading income |
0.4 |
|
26.2 |
|
103.3 |
|
82.6 |
|
— |
|
212.5 |
Interest income/(expense) |
123.8 |
|
3.1 |
|
(1.7) |
|
— |
|
(65.2) |
|
60.0 |
Inter-segmental funding allocations2 |
(54.4) |
|
(1.5) |
|
(12.2) |
|
(19.3) |
|
87.4 |
|
— |
Net
interest income/(expense) |
69.4 |
|
1.6 |
|
(13.9) |
|
(19.3) |
|
22.2 |
|
60.0 |
Net
physical commodities income |
— |
|
— |
|
2.7 |
|
— |
|
— |
|
2.7 |
Revenue |
193.9 |
|
252.3 |
|
90.7 |
|
63.3 |
|
22.2 |
|
622.4 |
Adjusted operating profit/(loss) |
98.6 |
|
26.9 |
|
24.8 |
|
19.2 |
|
(45.0) |
|
124.5 |
|
|
|
|
|
|
|
|
|
|
|
|
Other segment
information |
|
|
|
|
|
|
|
|
|
|
|
Depreciation and amortisation |
(0.1) |
|
(0.4) |
|
(0.1) |
|
(0.1) |
|
(14.2) |
|
(14.9) |
1. The Group changed its reporting segments during 2023; as such
segment information for the comparative periods have been restated.
Refer to note 6 segmental analysis in the 2023 Group Annual Report
for further detail.
2.The Inter-segmental funding allocation represents the interest
costs borne by the Group, excluding interest earned centrally on
house cash balances, which is subsequently recharged to the
business segments. The recharge is based on the funding
requirements of each business.
Reconciliation of total segments adjusted operating
profit to the Group's profit before tax per the income
statement:
|
Six months ended |
|
Six months ended |
|
30 June 2024 |
|
30 June 2023 |
|
$m |
|
$m |
Total segments Adjusted Operating Profit |
159.2 |
|
124.5 |
Goodwill impairment
charge1 |
— |
|
(10.7) |
Bargain purchase gain2 |
— |
|
0.3 |
Acquisition costs3 |
— |
|
(0.5) |
Amortisation of acquired brands
and customer lists4 |
(2.6) |
|
(0.8) |
Activities in relation to
shareholders5 |
(2.4) |
|
— |
Employer tax on vesting of the
growth shares6 |
(2.2) |
|
— |
Owner fees7 |
(2.4) |
|
(3.3) |
IPO preparation costs8 |
(8.3) |
|
— |
Fair
value of the cash settlement option on the growth shares9 |
(2.3) |
|
— |
Profit before tax |
139.0 |
|
109.5 |
1. Goodwill impairment charges in 2023 relates to the impairment
recognised for goodwill relating to the Volatility Performance Fund
S.A. CGU (‘VPF’) largely due to declining projected revenue.
2. A bargain purchase gain was recognised as a result of the
ED&F Man Capital Markets division acquisition.
3. Acquisition costs are costs, such as legal fees incurred in
relation to the business acquisitions of ED&F Man Capital
Markets business, the OTCex group and Cowen's Prime Services and
Outsourced Trading business.
4. This represents the amortisation charge for the year/period
of acquired brands and customers lists.
5. Activities in relation to shareholders primarily consist of
dividend-like contributions made to participants within certain of
our share-based payments schemes. In prior years, this balance was
presented as part of amortisation of acquired brands and customer
lists.
6. Employer tax on vesting of the growth shares represents the
Group's tax charge arising from the vesting of the growth
shares.
7. Owner fees relate to management services to parties
associated with the former ultimate controlling party based on a
percentage of the Group’s profitability. Owner fees are excluded
from operating expenses as they do not form part of the operation
of the business and ceased to be incurred after the completion of
our offering.
8. IPO preparation costs related to consulting, legal and audit
fees, presented in the income statement within other expenses.
9. Fair value of the cash settlement option on the growth shares
represents the fair value liability of the growth shares at $2.3m.
Subsequent to the initial public offering when the holders of the
growth shares elected to take equity, the liability was
derecognised.
The Group’s Revenue and non-current assets by subsidiary
company’s country of domicile is as follows. In presenting
geographical information, revenue is based on the geographic
location of the legal entity where the customers' revenue is
recorded. Non-current assets are based on the geographic location
of the legal entity where the assets are recorded.
|
Revenue |
|
Non-current assets |
|
Six months ended |
Six months ended |
|
|
|
|
30 June 2024 |
30 June 2023 |
|
30 June 2024 |
31 December 2023 |
|
$m |
$m |
|
$m |
$m |
United Kingdom |
398.4 |
318.9 |
|
255.2 |
234.7 |
United States |
261.4 |
210.6 |
|
49.3 |
46.3 |
Rest of
the world |
128.1 |
92.9 |
|
13.1 |
12.0 |
Total |
787.9 |
622.4 |
|
317.6 |
293.0 |
The balances in Rest of the world mainly consist of those from
countries in Europe and the Asia Pacific region, none of which are
individually material for separate disclosure.
Non-current assets for this purpose consist of goodwill,
intangible assets, property, plant and equipment, right-of-use
assets, investments, and investment in associate.
Contract assets
There were no assets that meet the definition of a contract
asset as at 30 June 2024 (31 December 2023: $nil).
5 Tax
The effective rate of tax on profit before tax is 26.0% for the
period ended 30 June 2024 (H1 2023: 26.20%). The statutory
rate of UK corporation tax increased from 19% to 25% on 1 April
2023. This results in a blended effective rate of 23.50% for the
year ended 31 December 2023 and 25% from 1 January 2024 with
respect to the UK. In addition, the Group incurred material
non-deductible acquisition and IPO preparation expenses which are
materially offset by deductions taken in respect of interest on the
Group's AT1 issuance.
6 Dividends Paid and Proposed
Dividends of $44.1m were paid to ordinary shareholders and $6.6m
to holders of AT1 securities during the period ended 30 June 2024
(30 June 2023: ordinary: $24.5m, AT1: $6.6m). Please refer to note
19 for Dividends that are proposed and expected to be paid
post period end.
7 Business Combinations
(a) Disposal of Marex North America LLC
On 3 January 2024, the Group disposed of one of its regulated
subsidiaries in the United States, Marex North America LLC ('MNA'),
to an external buyer for proceeds of $127.5m, constituting $125.0m
for the net assets of the business resulting in a gain on sale of
$2.5m.
Prior to the disposal, during 2023, the business of MNA was
transferred to another affiliate, Marex Capital Markets Inc. The
entity being disposed of qualified as a disposal group under IFRS
5. However, as the only asset that the entity held at the balance
sheet date was a receivable related to intragroup debt, which
eliminates on consolidation, the entity was not disclosed as a
disposal group.
(b) Acquisition of Pinnacle Fuel LLC
On 5 January 2024, the Group acquired Pinnacle Fuel LLC
('Pinnacle') from Empire Holdings LLC for a consideration of $4.0m
which is split as $3.7m of goodwill premium and $0.3m of intangible
assets relating to customer lists, the net assets of Pinnacle were
immaterial. Pinnacle is a physical oil trading business and has
been purchased by Marex North America Holdings Inc in order to
facilitate the growth of its back-to-back oil trading business
(c) Acquisitions for the six months ended 30 June
2023
For the acquisitions for the six months ended 30 June 2023,
refer to the 2023 Group Annual Report.
8 Goodwill
An impairment of goodwill was recorded during the six months
period ended 30 June 2023. The impairment charge was against the
Volatility Performance Fund S.A. CGU (‘VPF’). The VPF’s projected
future net revenues as well as the growth assumptions were based
upon the most recent performance in 2022. As as highlighted in the
2023 Group Annual Report, 2023 was a challenging year for the VPF,
and these challenging conditions resulted in the recoverable amount
for the VPF being $6.0m based upon its VIU which was lower than its
carrying value of $16.7m and an impairment charge of $10.7m was
recognised due to the combination of projected performance and
macroeconomic factors.
As at 30 June 2024, the review of the indicators of impairment
did not require any further testing.
9 Trade and Other Receivables
|
30 June 2024 |
|
31 December 2023 |
|
$m |
|
$m |
Amounts due from exchanges, clearing houses and other
counterparties |
2,675.8 |
|
3,459.6 |
Trade debtors |
1,176.0 |
|
823.8 |
Default funds and
deposits |
365.2 |
|
273.2 |
Loans receivable |
17.0 |
|
8.0 |
Other tax and social security
taxes |
13.8 |
|
10.8 |
Other debtors |
141.0 |
|
194.2 |
Prepayments |
24.7 |
|
20.2 |
|
4,413.5 |
|
4,789.8 |
Included in the amounts due from exchanges, clearing houses and
other counterparties are segregated balances of $1,056.1m
(2023: $1,699.5m) and non-segregated balances of $1,619.7m
(2023: $1,760.1m).
Other debtors includes amounts related to sign-on bonuses of
$39.6m (2023: $39.5m).
10 Derivative Instruments
Derivative assets and derivative liabilities comprise the
following:
|
30 June 2024 |
|
31 December 2023 |
Financial assets |
$m |
|
$m |
|
|
|
Restated1 |
Held for trading derivatives carried at fair value through profit
and loss that are not designated in hedge accounting
relationships: |
|
|
|
Synthetic equity swap |
229.9 |
|
177.1 |
Agriculture forward
contracts |
162.1 |
|
123.8 |
Agriculture option
contracts |
74.8 |
|
48.1 |
Energy forward contracts |
65.6 |
|
63.3 |
Energy option contracts |
3.7 |
|
5.5 |
Foreign currency forward
contracts |
122.5 |
|
143.3 |
Foreign currency option
contracts |
12.4 |
|
13.4 |
Precious metal forward
contracts |
— |
|
0.1 |
Credit forward contracts |
1.9 |
|
2.8 |
Metals forward contracts |
12.0 |
|
11.5 |
Equity forward contracts |
0.7 |
|
0.3 |
Equity option contracts |
21.4 |
|
24.5 |
Crypto forward contracts |
0.5 |
|
0.1 |
Crypto option contracts |
0.3 |
|
— |
Rates forward contracts |
10.9 |
|
11.8 |
Rates option contracts |
7.3 |
|
0.1 |
Held for trading derivatives
that are designated in hedge accounting relationships: |
|
|
|
Foreign currency forward
contracts |
1.9 |
|
3.1 |
Lease forward contracts |
0.1 |
|
— |
Interest rate swaps |
2.8 |
|
23.8 |
Cross
currency swaps |
— |
|
3.0 |
|
730.8 |
|
655.6 |
1. Certain prior period comparatives have been restated. Refer
to note 2(c) for further information.
|
30 June 2024 |
|
31 December 2023 |
Financial liabilities |
$m |
|
$m |
|
|
|
Restated1 |
Held for trading derivatives carried at fair value through profit
and loss that are not designated in hedge accounting
relationships: |
|
|
|
Agriculture forward
contracts |
128.7 |
|
106.4 |
Agriculture option
contracts |
53.4 |
|
25.1 |
Energy forward contracts |
59.1 |
|
49.1 |
Energy option contracts |
8.0 |
|
7.8 |
Foreign currency forward
contracts |
117.5 |
|
89.0 |
Foreign currency option
contracts |
14.2 |
|
14.5 |
Precious metal forward
contracts |
4.6 |
|
2.6 |
Credit forward |
1.4 |
|
1.7 |
Credit option contracts |
6.1 |
|
— |
Interest rate forward
contracts |
21.9 |
|
12.9 |
Interest rate options
contracts |
7.3 |
|
0.2 |
Crypto forward |
2.9 |
|
14.9 |
Crypto option |
10.9 |
|
19.3 |
Equity forward contracts |
7.0 |
|
24.0 |
Equity option contracts |
26.1 |
|
28.9 |
Metals forward |
13.9 |
|
5.6 |
Metal option contracts |
0.3 |
|
— |
Held for trading derivatives
that are designated in hedge accounting relationships: |
|
|
|
Foreign currency forward
contracts |
0.1 |
|
0.2 |
Interest rate swaps |
4.2 |
|
— |
Cross
currency swaps |
9.2 |
|
— |
|
496.8 |
|
402.2 |
1. Certain prior period comparatives have been restated. Refer
to note 2(c) for further information.
11 Trade and Other Payables
|
|
|
|
|
|
30 June 2024 |
|
31 December 2023 |
|
|
$m |
|
$m |
|
Trade payables |
6,523.3 |
|
5,908.5 |
|
Amounts due to exchanges,
clearing houses and other counterparties |
105.7 |
|
432.4 |
|
Other tax and social security
taxes |
17.6 |
|
9.9 |
|
Other creditors |
43.6 |
|
21.7 |
|
Accruals |
434.7 |
|
412.9 |
|
Deferred income |
3.7 |
|
0.5 |
|
|
7,128.6 |
|
6,785.9 |
|
Included in trade payables and amounts due to exchanges,
clearing houses and other counterparties are segregated balances of
$3,538.5m (2023: $3,820.2m) and non-segregated balances of
$3,090.5m (2023: $2,520.7m).
12 Share Capital
In connection with the IPO, in April 2024, the following steps
were taken to reorganise share capital. Such steps were completed
immediately before the completion of the IPO:
1. Ordinary shares reorganisation
a) 24,892,848 Growth Shares of $0.000165 were reorganised as the
following:
- The growth options were exercised which created 185,894 new
growth shares.
- 25,078,742 Growth Shares of $0.000165 were converted into
15,148,855 Ordinary Shares of $0.000165 and 9,929,887 deferred
shares of $0.000165 upon the occurrence of the IPO.
- 9,929,887 deferred shares of $0.000165 which were redenominated
and consolidated to 2,806,815 Deferred Shares of £0.000469 by using
the exchange rate equal to the average closing rate of exchange for
the five days up to and ended 19 April 2024 for the relevant
currency paid of USD/GBP $1.2446/£1.
- All 3,986,376 Non-voting Ordinary Shares as at 1 January 2024
and new issuance of 875,171 Non-voting Ordinary Shares to the
holder of the warrant issued in 2012 and exercised before the
occurrence of the IPO were reclassified to 4,861,547 Ordinary
Shares of $0.000165.
b) In addition, 2,039,124 ordinary shares of $0.000165 were
issued in the capital of the Company to the Employee Benefit Trust
Limited in its role as nominee for the holders of Growth Shares in
satisfaction of the of dividends paid by Marex since the issuance
of series 2016, 2019 and 2020 Growth shares in accordance with the
terms upon which they were issued.
2. Reverse Share Split
All 128,541,114 Ordinary Shares of $0.000165 were consolidated
into 68,375,690 Ordinary Shares of $0.001551 at a conversion rate
of 1:88 to 1.
3. Deferred Share Cancellation
106,168,869 Deferred Shares of £0.000469 each in the share
capital of the Company were cancelled.
The Deferred shares have no voting rights, no right to
participate in dividends or distributions and no right to
redemption. On a return of capital on a winding up or otherwise,
the assets of the Company available for distribution to its members
shall be applied in paying a sum equal to £1 to the holders of the
deferred shares pro rata according to the number of deferred shares
held by them (rounded to the nearest £0.01, but such that the total
paid in aggregate to all the holders shall in no event exceed
£1).
As part of the initial public offering, 3,846,153 Ordinary
Shares of US$0.001551 each in the share capital of the Company were
then issued, the sale of shares raised $68.3m in cash, with issue
costs of $4.7m.
The following is a roll forward analysis of the share movements
outlining the share capital reorganisation completed prior to the
IPO
|
Ordinary shares of $0.001551 Number |
|
Ordinary shares of $0.000165 Number |
|
Non-voting Ordinary Shares of $0.000165 Number |
|
Deferred Shares of £0.000469Number |
|
Growth Shares of $0.000165 Number |
|
TotalNumber |
At 1 January 2024 |
— |
|
106,491,588 |
|
3,986,376 |
|
107,491,490 |
|
24,892,848 |
|
242,862,302 |
Ordinary shares reorganisation pre-IPO (1) |
— |
|
22,049,526 |
|
(3,986,376) |
|
2,806,815 |
|
(24,892,848) |
|
(4,022,883) |
Total: Post ordinary shares
reorganisation |
— |
|
128,541,114 |
|
— |
|
110,298,305 |
|
— |
|
238,839,419 |
Reverse share split (2) |
68,375,690 |
|
(128,541,114) |
|
— |
|
— |
|
— |
|
(60,165,424) |
Deferred share cancellation (3) |
— |
|
— |
|
— |
|
(106,168,869) |
|
— |
|
(106,168,869) |
Total: Post share capital reorganisation |
68,375,690 |
|
— |
|
— |
|
4,129,436 |
|
— |
|
72,505,126 |
IPO |
3,846,153 |
|
— |
|
— |
|
— |
|
— |
|
3,846,153 |
At 30 June 2024 |
72,221,843 |
|
— |
|
— |
|
4,129,436 |
|
— |
|
76,351,279 |
The following is a summary of the shares outstanding for
the respective periods.
The rights of the other shares are disclosed in the 2023 Group
Annual Report and Accounts consolidated financial statements.
|
Issued and fully paid |
|
Issued and fully paid1 |
|
2024 |
|
2024 |
|
2023 |
|
2023 |
|
Number |
|
$'000 |
|
Number |
|
$'000 |
Ordinary Shares of $0.000165 each |
— |
|
— |
|
106,491,588 |
|
18 |
Ordinary Shares of $0.001551
each |
72,221,843 |
|
112 |
|
— |
|
— |
Non-voting Ordinary Shares of
$0.000165 each |
— |
|
— |
|
3,986,376 |
|
1 |
Deferred Shares of £0.000469
each |
4,129,436 |
|
3 |
|
107,491,490 |
|
69 |
Growth
Shares of $0.000165 each |
— |
|
— |
|
24,892,848 |
|
4 |
|
76,351,279 |
|
115 |
|
242,862,302 |
|
92 |
1) These are as at 31 December 2023 prior to the Group's share
reorganisation which occurred in April 2024.
13 Leases
|
Right-of-use asset |
|
30 June 2024 |
|
31 December 2023 |
|
$m |
|
$m |
As at 1 January |
40.6 |
|
33.7 |
Additions during the year |
32.9 |
|
22.8 |
Adjustment to initial
recognition of right-of-use asset |
0.6 |
|
(1.0) |
Lease incentive |
(8.0) |
|
— |
Depreciation charged to income
statement |
(5.4) |
|
(9.7) |
Impairment of right-of-use asset |
(0.1) |
|
(5.2) |
Balance at end of period |
60.6 |
|
40.6 |
|
Lease liability |
|
30 June 2024 |
|
31 December 2023 |
|
$m |
|
$m |
As at 1 January |
52.6 |
|
38.9 |
Additions during the year |
32.9 |
|
22.8 |
Interest expense charged to
income statement |
1.2 |
|
2.5 |
Payment of lease
liabilities |
(7.7) |
|
(11.4) |
Foreign exchange
revaluation |
(0.6) |
|
(0.1) |
Lease
incentive |
— |
|
(0.1) |
Balance at end of period |
78.4 |
|
52.6 |
|
Lease liability |
|
30 June 2024 |
|
31 December 2023 |
|
$m |
|
$m |
Current liability |
13.0 |
|
13.2 |
Non-current liability |
65.4 |
|
39.4 |
Balance at end of period |
78.4 |
|
52.6 |
The weighted average incremental borrowing rate applied to lease
liabilities recognised in the statement of financial position as at
30 June 2024 is 6.53% (31 December 2023: 5.16%).
The Group has extended the lease for the 4th and 5th floor at
155 Bishopsgate, London and has also taken on the lease for the 3rd
floor of the same building. The lease terms will run until 2035
with a liability of $31.8m.
The Group has the following leases that have the option of
extension at the end of the lease term:
- Greenway Plaza, Houston – five
years;
- Asia Square Towers, Singapore –
three years;
- 45th street, New York – five
years;
- Montreal – five years;
- Milton Park, Alpharetta, Georgia –
five years;
- Embarcadero Center, San Francisco
– five years;
- Crescent Court, Dallas, Texas – five
years.
The maturities of the undiscounted lease liabilities as at 30
June/31 December are as follows:
|
Lease liability |
|
30 June 2024 |
|
31 December 2023 |
|
$m |
|
$m |
1 year |
14.2 |
|
13.8 |
1 to 5 years |
33.4 |
|
31.5 |
More
than 5 years |
56.2 |
|
12.5 |
|
103.8 |
|
57.8 |
Less:
future interest expense |
(25.4) |
|
(5.2) |
|
78.4 |
|
52.6 |
14 Financial Instruments
This note explains the methodology for valuing our assets and
liabilities measured at fair value and for fair value disclosures.
It also provides an analysis of these according to a fair value
hierarchy, determined by the market observability of valuation
inputs.
(a) Liquidity risk
The Group defines liquidity risk as the failure to meet its
day-to-day capital and cash flow requirements. Liquidity risk is
assessed and managed under the Internal Capital Adequacy and Risk
Assessment (ICARA), as required under UK IFPR regulation and the
Group’s internal Liquidity Risk Framework. To mitigate liquidity
risk, the Group has implemented robust cash management policies and
procedures that monitor liquidity daily to ensure that the Group
has sufficient resources to meet its margin requirement at clearing
houses and third-party brokers. In the event of a liquidity issue
arising, the Group has recourse to existing global cash resources,
after which it could draw down on $275m (31 December 2023: $250m)
of committed revolving credit facilities. The Group has access to a
further $125m (31 December 2023: $125m) secured borrowings.
The effect of the early redemption features within the
structured note program is monitored and dynamically updated to
reflect any changes to expected cashflows as part of the overall
Group liquidity requirements. Short term liquidity requirements are
monitored and subject to limits reflecting the Group's liquidity
resources.
The Group has strict guidelines in relation to products and
tenor into which excess liquidity can be invested. Excess liquidity
is invested in highly liquid instruments, such as cash deposits
with financial institutions for a period of less than 3 months,
short-term money market funds and US Treasuries with a maturity of
up to 3 years.
The financial liabilities are based upon rates set on a daily
basis, apart from the financing of the warrant positions and the
credit facility where the rates are set for the term of the loan.
For assets not marked-to-market, there is no material difference
between the carrying value and fair value.
Liquidity risk exposures
The following table details the Group’s available committed
borrowing facilities:
Committed revolving credit facilities: |
30 June 2024 |
|
31 December 2023 |
|
$m |
|
$m |
Amount used |
— |
|
— |
Amount unused |
275.0 |
|
250.0 |
|
275.0 |
|
250.0 |
The following table details the Group’s contractual maturity for
non-derivative financial liabilities. Debt securities are presented
discounted based on the first call dates. Lease liabilities are
undiscounted and contractual.
|
On demand |
|
Less than 3months |
|
3 to 12months |
|
1 to 5 years |
|
More than 5 years |
|
Total |
30 June
2024 |
$m |
|
$m |
|
$m |
|
$m |
|
$m |
|
$m |
Repurchase agreements |
1,411.6 |
|
432.8 |
|
— |
|
— |
|
— |
|
1,844.4 |
Short securities |
1,734.9 |
|
1.7 |
|
— |
|
— |
|
— |
|
1,736.6 |
Amounts due to exchanges,
clearing houses and other counterparties |
59.3 |
|
46.4 |
|
— |
|
— |
|
— |
|
105.7 |
Trade payables |
6,200.5 |
|
322.8 |
|
— |
|
— |
|
— |
|
6,523.3 |
Other creditors |
24.1 |
|
8.4 |
|
11.0 |
|
0.1 |
|
— |
|
43.6 |
Stock lending |
2,563.1 |
|
— |
|
— |
|
— |
|
— |
|
2,563.1 |
Debt securities |
— |
|
981.1 |
|
500.9 |
|
951.1 |
|
13.2 |
|
2,446.3 |
Lease liabilities |
— |
|
3.6 |
|
10.6 |
|
33.4 |
|
56.2 |
|
103.8 |
|
11,993.5 |
|
1,796.8 |
|
522.5 |
|
984.6 |
|
69.4 |
|
15,366.8 |
|
On demand |
|
Less than 3months |
|
3 to 12months |
|
1 to 5 years |
|
More than 5 years |
|
Total |
31
December 2023 |
$m |
|
$m |
|
$m |
|
$m |
|
$m |
|
$m |
Repurchase agreements |
— |
|
3,118.9 |
|
— |
|
— |
|
— |
|
3,118.9 |
Short securities |
1.3 |
|
1,923.5 |
|
— |
|
— |
|
— |
|
1,924.8 |
Amounts due to exchanges,
clearing houses and other counterparties |
432.4 |
|
— |
|
— |
|
— |
|
— |
|
432.4 |
Trade payables |
5,725.2 |
|
183.3 |
|
— |
|
— |
|
— |
|
5,908.5 |
Other creditors |
8.9 |
|
10.7 |
|
2.1 |
|
— |
|
— |
|
21.7 |
Stock lending |
— |
|
2,323.3 |
|
— |
|
— |
|
— |
|
2,323.3 |
Debt securities |
— |
|
440.2 |
|
868.2 |
|
889.4 |
|
18.5 |
|
2,216.3 |
Lease liabilities |
— |
|
3.4 |
|
10.4 |
|
31.5 |
|
12.5 |
|
57.8 |
|
6,167.8 |
|
8,003.3 |
|
880.7 |
|
920.9 |
|
31.0 |
|
16,003.7 |
Amounts due to exchanges, clearing houses and other
counterparties, trade payables and other creditors are aggregated
on the statement of financial position in trade and other
payables.
Shown below is the Group’s contractual maturity for
non-derivative financial assets:
30 June 2024 |
On demand$m |
|
Less than 3months$m |
|
3 to 12months$m |
|
1 to 5 years$m |
|
More than 5 years$m |
|
Total$m |
Treasury instruments |
— |
|
2,288.2 |
|
741.0 |
|
5.9 |
|
— |
|
3,035.1 |
Equity instruments |
2,515.5 |
|
31.0 |
|
— |
|
— |
|
— |
|
2,546.5 |
Stock borrowing |
1,795.5 |
|
— |
|
— |
|
— |
|
— |
|
1,795.5 |
Reverse repurchase
agreements |
439.9 |
|
1,573.3 |
|
91.1 |
|
— |
|
— |
|
2,104.3 |
Amounts due from exchanges,
clearing houses and other counterparties |
2,581.5 |
|
32.7 |
|
59.8 |
|
1.4 |
|
— |
|
2,675.4 |
Trade debtors |
1,019.2 |
|
129.7 |
|
25.2 |
|
1.6 |
|
0.3 |
|
1,176.0 |
Default funds and
deposits |
173.4 |
|
191.5 |
|
0.3 |
|
— |
|
— |
|
365.2 |
Loans receivable |
11.2 |
|
1.0 |
|
0.1 |
|
4.7 |
|
— |
|
17.0 |
Other debtors |
21.6 |
|
64.3 |
|
12.5 |
|
1.4 |
|
1.7 |
|
101.5 |
Cash
and cash equivalents |
1,914.2 |
|
— |
|
— |
|
— |
|
— |
|
1,914.2 |
|
10,472.0 |
|
4,311.7 |
|
930.0 |
|
15.0 |
|
2.0 |
|
15,730.7 |
31 December 2023 |
On demand$m |
|
Less than 3months$m |
|
3 to 12months$m |
|
1 to 5 years$m |
|
More than 5 years$m |
|
Total$m |
Treasury instruments |
— |
|
2,396.6 |
|
104.8 |
|
119.7 |
|
— |
|
2,621.1 |
Equity instruments |
1,511.9 |
|
9.4 |
|
— |
|
— |
|
— |
|
1,521.3 |
Stock borrowing |
2,501.4 |
|
— |
|
— |
|
— |
|
— |
|
2,501.4 |
Reverse repurchase
agreements |
— |
|
3,199.8 |
|
— |
|
— |
|
— |
|
3,199.8 |
Amounts due from exchanges,
clearing houses and other counterparties |
3,297.2 |
|
— |
|
— |
|
— |
|
— |
|
3,297.2 |
Trade debtors |
468.2 |
|
206.7 |
|
11.8 |
|
1.1 |
|
— |
|
687.8 |
Default funds and
deposits |
17.3 |
|
121.5 |
|
134.3 |
|
0.1 |
|
— |
|
273.2 |
Loans receivable |
— |
|
7.7 |
|
0.4 |
|
— |
|
— |
|
8.1 |
Other debtors |
142.2 |
|
11.3 |
|
0.5 |
|
0.1 |
|
0.6 |
|
154.7 |
Cash
and cash equivalents |
1,483.5 |
|
— |
|
— |
|
— |
|
— |
|
1,483.5 |
|
9,421.7 |
|
5,953.0 |
|
251.8 |
|
121.0 |
|
0.6 |
|
15,748.1 |
Both assets and liabilities are included to understand the
Group’s liquidity risk management, as the liquidity is managed on a
net asset and liability basis. Amounts due from exchanges, clearing
houses and other counterparties, trade debtors, default funds and
deposits, loans receivable and other debtors are aggregated on the
statement of financial position in trade and other receivables.
The following table details the Group’s contractual maturity for
derivative financial assets and derivative financial
liabilities:
30 June 2024 |
On demand |
|
Less than 3months |
|
3 to 12months |
|
1 to 5 years |
|
5 + years |
|
Total |
Derivative instruments |
$m |
|
$m |
|
$m |
|
$m |
|
$m |
|
$m |
Assets |
— |
|
240.8 |
|
220.4 |
|
268.2 |
|
1.4 |
|
730.8 |
Liabilities |
— |
|
(224.8) |
|
(213.9) |
|
(48.6) |
|
(9.5) |
|
(496.8) |
|
— |
|
16.0 |
|
6.5 |
|
219.6 |
|
(8.1) |
|
234.0 |
31 December 2023 |
On demand |
|
Less than 3months |
|
3 to 12months |
|
1 to 5 years |
|
5 + years |
|
Total |
Derivative instruments |
$m |
|
$m |
|
$m |
|
$m |
|
$m |
|
$m |
Assets (Restated1) |
— |
|
255.3 |
|
139.9 |
|
258.0 |
|
2.4 |
|
655.6 |
Liabilities (Restated1) |
— |
|
(248.9) |
|
(109.0) |
|
(42.5) |
|
(1.8) |
|
(402.2) |
|
— |
|
6.4 |
|
30.9 |
|
215.5 |
|
0.6 |
|
253.4 |
1. Certain prior period comparatives have been restated. Refer
to note 2(c) for further information.
Certain derivative assets and liabilities do not meet the
offsetting criteria in IAS 32, but the entity has the right of
offset in the case of default, insolvency or bankruptcy.
Consequently, the net amount of derivative assets presented of
$730.8m (31 December 2023: $655.6m) and the net amount of
derivative liabilities presented of $496.8m (31 December 2023:
$402.2m) are disclosed separately in the Group's statement of
financial position.
(b) Fair value measurement
The information set out below provides information about how the
Group determines fair values of various financial assets and
financial liabilities.
Management assessed that the fair values of treasury
instruments, stock borrowing, reverse repurchase agreements,
amounts due from exchanges, clearing houses and other
counterparties, cash and short term deposits, trade receivables,
repurchase agreements, stock lending and trade and other payables,
approximate their carrying value amounts largely due to the
short-term maturities of these instruments.
The following methods and assumptions were used to estimate the
Level 2 fair values:
- The fair values of the debt
securities takes the price quotations at the reporting date and
compares them against internal quantitative models that require the
use of multiple market inputs including commodities prices,
interest and foreign exchange rates to generate a continuous
yield or pricing curves and volatility factors, which are used to
value the position.
- The fair value of non-listed
investments relates to the Group’s holding of seats and membership
of the exchanges and is based upon the latest trading price.
- Where the inventory is related to
scrap metals, the valuation is based on the quoted price discounted
by location and grade of metal. Where there is an active market for
the Group’s inventory, then quoted market price will be used to
value the inventory position.
- The Group enters into derivative
financial instruments with various counterparties, principally
financial institutions with investment grade credit ratings.
Interest rate swaps, foreign exchange forward contracts and
commodity forward contracts are valued using valuation techniques,
which employ the use of market observable inputs. The most
frequently applied valuation techniques include forward pricing and
swap models using present value calculations. The models
incorporate various inputs including the credit quality of
counterparties, foreign exchange spot and forward rates curves of
the underlying commodity. Some derivative contracts are fully cash
collateralised, thereby eliminating both counterparty risk and the
Group’s own non-performance risk.
Level 3 fair value measurements are those derived from valuation
techniques that include inputs for the asset or liability that are
not based on observable market data. Some of the Group’s
derivative financial instruments are priced using quantitative
models that require the use of multiple market inputs including
commodity prices, interest and foreign exchange rates to generate
continuous yield or pricing curves and volatility factors in
addition to unobservable inputs, which are used to value the
position and therefore qualify as Level 3 financial assets.
|
Level 1 |
|
Level 2 |
|
Level 3 |
|
Total |
30 June
2024 |
$m |
|
$m |
|
$m |
|
$m |
Financial assets – FVTPL: |
|
|
|
|
|
|
|
Equity instruments |
2,546.5 |
|
— |
|
— |
|
2,546.5 |
Derivative instruments |
8.1 |
|
720.0 |
|
0.7 |
|
728.8 |
Trade debtors |
18.6 |
|
— |
|
— |
|
18.6 |
Inventory |
105.9 |
|
17.1 |
|
— |
|
123.0 |
Financial assets –
FVTOCI: |
|
|
|
|
|
|
|
Investments |
6.4 |
|
11.1 |
|
— |
|
17.5 |
Derivative instruments |
— |
|
2.0 |
|
— |
|
2.0 |
Financial liabilities
– FVTOCI: |
|
|
|
|
|
|
|
Derivative instruments |
— |
|
(0.1) |
|
— |
|
(0.1) |
Financial liabilities
– FVTPL: |
|
|
|
|
|
|
|
Derivative instruments |
(5.8) |
|
(489.6) |
|
(1.4) |
|
(496.8) |
Trade payables |
(5.8) |
|
— |
|
— |
|
(5.8) |
Short securities |
(1,736.6) |
|
— |
|
— |
|
(1,736.6) |
Debt
securities |
— |
|
(2,112.1) |
|
(1.2) |
|
(2,113.3) |
|
937.3 |
|
(1,851.6) |
|
(1.9) |
|
(916.2) |
|
Level 1 |
|
Level 2 |
|
Level 3 |
|
Total |
31
December 2023 |
$m |
|
$m |
|
$m |
|
$m |
Financial assets – FVTPL: |
|
|
|
|
|
|
|
Equity instruments |
1,521.3 |
|
— |
|
— |
|
1,521.3 |
Derivative instruments
(Restated1) |
1.1 |
|
650.6 |
|
0.8 |
|
652.5 |
Trade debtors |
5.6 |
|
— |
|
— |
|
5.6 |
Inventory |
144.5 |
|
18.9 |
|
— |
|
163.4 |
Financial assets –
FVTOCI: |
|
|
|
|
|
|
|
Investments |
5.5 |
|
10.7 |
|
— |
|
16.2 |
Derivative instruments |
— |
|
3.1 |
|
— |
|
3.1 |
Financial liabilities
– FVTOCI: |
|
|
|
|
|
|
|
Derivative instruments |
— |
|
(0.2) |
|
— |
|
(0.2) |
Financial liabilities
– FVTPL: |
|
|
|
|
|
|
|
Derivative instruments
(Restated1) |
(2.2) |
|
(396.8) |
|
(3.0) |
|
(402.0) |
Trade payables |
(5.6) |
|
— |
|
— |
|
(5.6) |
Short securities |
(1,924.8) |
|
— |
|
— |
|
(1,924.8) |
Debt
securities |
— |
|
(1,854.9) |
|
(3.0) |
|
(1,857.9) |
|
(254.6) |
|
(1,568.6) |
|
(5.2) |
|
(1,828.4) |
1. Certain prior period comparatives have been restated. Refer
to note 2(c) for further information.
The following table summarises the movements in the Level 3
balances during the period.
Asset and liability transfers between Level 2 and Level 3 are
primarily due to either an increase or decrease in observable
market activity related to an input or a change in the
significance of the unobservable input, with assets and liabilities
classified as Level 3 if an unobservable input is deemed
significant. There were no transfers between any other levels
during the period (31 December 2023: no transfers).
(c) Reconciliation of Level 3 fair value measurements of
financial assets
|
30 June 2024 |
|
31 December 2023 |
|
$m |
|
$m |
Balance at beginning of period |
0.8 |
|
2.6 |
Purchases |
— |
|
— |
Settlements |
(0.3) |
|
(2.4) |
Total gains or losses in the period recognised in the
income statement: |
|
|
|
Market Making revenue |
0.3 |
|
0.6 |
Transfers out of Level 3 |
(0.1) |
|
— |
Balance at end of period |
0.7 |
|
0.8 |
Reconciliation of Level 3 fair value measurements of
financial liabilities
|
30 June 2024 |
|
31 December 2023 |
|
$m |
|
$m |
Balance at beginning of period |
6.0 |
|
4.8 |
Purchases |
— |
|
0.6 |
Settlements |
(1.6) |
|
(0.7) |
Total gains or losses in the period recognised in the income
statement: |
|
|
|
Market Making revenue |
(0.4) |
|
2.9 |
Transfers out of Level 3 |
(2.0) |
|
(4.0) |
Transfers into Level 3 |
0.6 |
|
2.4 |
Balance at end of period |
2.6 |
|
6.0 |
The Group’s management believes, based on the valuation approach
used for the calculation of fair values and the related controls,
that the Level 3 fair values are appropriate. The impact of
reasonably possible alternative assumptions from the unobservable
input parameters shows no significant impact on the Group’s profit,
comprehensive income or shareholders’ equity. The Group deems the
total amount of Level 3 financial assets and liabilities to be
immaterial and therefore any sensitivities calculated on these
balances are also deemed to be immaterial. The Group defers day 1
gains/losses when the initial fair value of a financial instrument
held at fair value through profit and loss relies on unobservable
inputs. At 30 June 2024, the Group held a deferred day 1
gains/losses balance of $4.7m (31 December 2023 $3.1m).
(d) Debt securities
Financial Products Programs
In 2018 and September 2021, we launched our Structured Notes
Private Offer Program and Public Offer Program (together, the
'Financial Products Programs'), respectively, which are at the core
of our Financial Products business. The Financial Products business
is part of our Hedging and Investment solutions segment and
provides our clients with structured investment products (the
'Structured Notes') and represents a way to diversify our sources
of funding and to reduce the utilisation of our revolving credit
facilities. The Financial Products business allows investors to
build their own Structured Notes across numerous asset classes,
including commodities, equities, foreign exchange and fixed income
products.
Under the Financial Products Program, the Company and Marex
Financial (a subsidiary) may issue warrants, certificates or notes,
including auto callable, fixed, stability and capital linked notes
with varied terms. As at 30 June 2024, the Group had $2,112.8m (31
December 2023: $1,850.4m) of debt securities issued under the
Financial Products Program with an average expected maturity of 16
months (31 December 2023: 15 months) however some of those debt
securities issued include early redemption clauses exercised at the
election of the investor if the underlying conditions are met. The
average imputed interest rate of the notes was 7.1% (31 December
2023: 7.8%). These notes are designated at fair value through
profit and loss.
15 Client Money (segregated)
As required by the UK FCA’s Client Assets Sourcebook (‘CASS’)
rules and the CFTC’s client money rules, the Group maintains
certain balances on behalf of clients with banks, exchanges,
clearing houses and brokers in segregated accounts. Segregated
assets governed by the UK FCA's CASS rules and the related
liabilities to clients, whose recourse is limited to segregated
accounts, are not included in the Group’s statement of financial
position where the Group is not beneficially entitled thereto and
does not share any of the risks or rewards of the assets. Excess
Group cash placed in US segregated accounts to satisfy US
regulations and securities held in US segregated accounts are
recognised on the Group’s statement of financial position.
|
30 June 2024 |
|
31 December 2023 |
|
$m |
|
$m |
Segregated assets at banks (not recognised) |
4,565.6 |
|
4,116.4 |
Segregated assets at
exchanges, clearing houses and other counterparties (not
recognised) |
1,986.2 |
|
2,084.6 |
Segregated assets at exchanges, clearing houses and other
counterparties (recognised) |
3,985.8 |
|
4,415.6 |
|
10,537.6 |
|
10,616.6 |
As at 30 June 2024, $162.5m (31 December 2023: $197.7m) of
excess Group cash placed in segregated accounts to satisfy US
regulations has been recorded within cash and cash equivalents and
client liabilities within Trade and other payables in the statement
of financial position.
16 Earnings Per Share
Basic earnings per share is calculated by dividing the profit
attributable to the ordinary equity holders of the Group for the
six month period by the weighted average number of ordinary shares
outstanding during the period.
Diluted EPS is calculated by dividing the profit attributable to
ordinary equity holders of the Group (after adjusting for the
impact of AT1 securities dividends) by the weighted average number
of ordinary shares that would be issued on conversion of all the
dilutive potential ordinary shares into ordinary shares.
The following table reflects the income and share data used in
the basic and diluted EPS calculations:
|
Six months ended30 June 2024 |
|
Six months ended30 June 2023* |
Profit before tax ($m) |
139.0 |
|
109.5 |
Tax
($m) |
(36.1) |
|
(28.7) |
Profit after tax ($m) |
102.9 |
|
80.8 |
AT1
dividends paid ($m) |
(6.6) |
|
(6.6) |
Profit attributable to shareholders of the Group
($m) |
96.3 |
|
74.2 |
Weighted average
number of Ordinary shares during the period |
68,160,724 |
|
65,747,014 |
Basic earnings per share ($) |
1.41 |
|
1.13 |
Weighted average number of Ordinary shares for basic
EPS |
68,160,724 |
|
65,747,014 |
Effect of dilution from: |
|
|
|
Share schemes |
4,733,499 |
|
4,304,865 |
Weighted average
number of Ordinary shares adjusted for the effect of
dilution |
72,894,223 |
|
70,051,879 |
Diluted earnings per share ($) |
1.32 |
|
1.06 |
*The comparative weighted average number of ordinary shares has
been restated to reflect the share capital reorganisation. This
resulted in the weighted average number of shares outstanding
decreasing, impacting the calculation of basic and diluted earnings
per share. On 25th April a series of share capital reorganisation
steps were undertaken to re-denominate the share capital prior to
the completion of the IPO. Refer to Note 12 for more detail on the
share capital reorganisation.
There have been no other transactions involving ordinary shares
or potential ordinary shares between the reporting date and the
date of authorisation of these financial statements.
17 Related Party Transactions
(a) Parent and ultimate controlling party
Marex Group plc (the parent company) listed on the US stock
market (Nasdaq Global Select Market) and its ordinary shares began
trading on 25 April 2024 under the ticker symbol ‘MRX’.
As a result of the public listing, Amphitryon Limited a company
incorporated in Jersey, Channel Islands. is no longer the ultimate
controlling party.
(b) Key management personnel transactions
In May 2024, the Employee Benefit Trust acquired the beneficial
interest in 131,675 shares from key management personnel to
facilitate tax withholding payments relating to the vesting of
shares under the Company’s Deferred Benefit Plans.
(c) Transactions with entities having significant
influence over the Group
Balances and transactions between the Company and its
subsidiaries which are related parties have been eliminated on
consolidation and are not disclosed in this note.
On 20 October 2020, the Company entered into a Shareholders’
Agreement with Amphitryon Limited, Ocean Ring Jersey Co. Limited
and Ocean Trade Lux Co S.Á.R.L. (the '2020 Shareholders’
Agreement'). Pursuant to the terms of the 2020 Shareholders’
Agreement, the Group paid a management fee of 2.5% of EBITDA
each year to a party associated with the ultimate parent company
for services provided. For the six month period ending 30 June 2024
the Group paid $2.4m (30 June 2023: $3.4m), recorded within other
expenses. This agreement came to an end from the date of the public
listing. As at 30 June 2024, there was no outstanding payable
balance (31 December 2023: $1.1m recorded within trade and other
payables).
There were no other transactions during the period or assets and
liabilities outstanding as at 30 June 2024 (30 June 2023: $nil)
with other related parties.
18 Share-based payments
Share-based payment
The Group operates three equity-settled share-based remuneration
schemes for Executive Directors and senior management. All are
United Kingdom tax authority unapproved schemes. The cost of the
service is calculated by reference to the fair value of shares at
the grant date, the number of shares expected to vest under the
schemes and the probability that the performance and the service
conditions will be met. The fair values of the shares were
calculated by applying an estimated price-earnings multiple to the
earnings per share of the Group, which prior to grant was approved
at the Remuneration Committee. The cost of the service is
recognised in the income statement over the period that the
employee provides service and there is a shared understanding of
the terms and conditions of the arrangement. The employee to whom
these awards were granted must not depart from the Group, and such
an action would require a forfeiture of some or all of the award
depending on the conditions under which the employee were to
leave.
In connection with the IPO, the following steps were taken to
reorganise share capital. Further detail is provided in note 12
'Share Capital'.
New share-based payment schemes
Global Omnibus Plan
In connection with the IPO, in April 2024, the Group adopted the
Global Omnibus Plan, which provides for the grant of share options,
including incentive share options, conditional awards, restricted
shares, share appreciation rights or any other share- or cash-based
awards to eligible employees and non-employees. As of 30 June 2024,
no instruments have been granted under the Global Omnibus Plan.
Previous share-based payment schemes
Disclosed in the Group’s 2023 Annual Report, there were a number
of share based remuneration schemes which had been granted
historically. The instruments issued under those plans included
growth shares, nil cost options, growth options and warrants. The
triggering event for these instruments was the liquidity event
which occurred on 25 April 2024. All of those outstanding
instruments were settled in exchange for a number of the Group’s
ordinary shares.
As the IPO was a liquidity event, the following transactions
took place:
- All the holders of the growth shares
issued under the series granted in 2010, 2011 and 2015 elected for
them to be redeemed in non-voting ordinary shares instead of cash
and hence 10,842,848 growth shares were converted into
6,789,719 non-voting ordinary shares and 4,450,577 deferred
shares.
- The growth shares awarded under the
series granted in 2016, 2019 and 2020 vested. All the holders of
these growth shares elected for the award to be settled in shares
instead of cash and hence 14,050,000 growth shares were
converted into 8,236,326 non-voting ordinary shares and
5,398,810 deferred shares.
- The 2010 growth options were settled
through the issuance of 185,894 newly issued Growth Shares
which in turn was settled with the allocation of 122,810 non-voting
ordinary shares and 80,500 deferred shares.
- All the nil cost options were
exercised and 592,536 previously issued non-voting ordinary shares
were transferred to the holders of the options.
- The warrants granted in 2012 were
exercised and 875,171 non-voting ordinary shares were issued. The
warrants granted in 2019 on 268,282 non-ordinary shares were
terminated and instead, 142,709 ordinary shares will be issued on
or shortly following the twelve-month anniversary of the completion
date of our IPO. This award remains outstanding as of 30 June
2024.
The warrants granted in 2012 were exercised and 875,171
non-voting ordinary shares were issued. The warrants granted in
2019 on 268,282 non-ordinary shares were terminated and instead,
142,709 ordinary shares will be issued on or shortly following the
twelve-month anniversary of the completion date of our IPO. This
award remains outstanding as of 30 June 2024. All of the non-voting
ordinary shares of the Company were then reclassified as ordinary
shares by way of redesignation. Subsequently, in satisfaction of
the dividend entitlement associated with 2016, 2019 and 2020 growth
share awards, 2,039,124 shares were issued. All other instruments
issued under the previous share-based remuneration plans have been
settled. All the above transactions were settled immediately prior
to the IPO and subsequently subject to reverse ordinary share
split. The number of shares presented above reflect shares prior to
the reverse ordinary share split. See note 12 for further
information.
Deferred Bonus Plan
Members of the scheme are awarded a fixed number of ordinary
shares vesting in three equal tranches over the three years
following the date of grant. As the awards are based on the
employees’ annual performance, for accounting purposes the grant
date is deemed to be the beginning of the year for which the bonus
had been awarded.
Retention Long Term Incentive Plan
Members of the scheme are awarded a variable number of ordinary
shares three years after the grant date. The number of shares
awarded is determined by reference to a hurdle return on equity of
the Group and to growth targets for the profit after tax of the
Group over the three-year period.
Annual Long Term Incentive Plan
Members of the scheme are awarded a variable number of ordinary
shares three years after the grant date. The number of shares
awarded is determined by reference to financial underpins; the
first is a hurdle return on equity of the Group and the second
underpin is growth targets for the Adjusted Operating Profit Before
Tax over the three year period.
Share-based payments expense, including the expenses recognised
on settlement of previous schemes, has been recorded in the
accompanying condensed consolidated income statement as follows for
the six month ended 30 June 2024 and 2023:
|
Six months ended |
|
Six months ended |
|
30 June 2024 |
|
30 June 2023 |
|
$m |
|
$m |
Deferred Bonus Plan |
4.3 |
|
6.9 |
Retention Long Term Incentive
Plan |
0.7 |
|
2.3 |
Annual Long Term Incentive
Plan |
2.4 |
|
1.0 |
Fair
value of the cash settlement option on the growth shares |
2.3 |
|
— |
Total equity-settled share-based payments |
9.7 |
|
10.2 |
Movement on share awards
|
30 June 2024 |
|
31 December 2023 |
|
Number |
|
Number |
Outstanding at the beginning of the period |
8,621,240 |
|
5,835,142 |
Reverse share split1 |
(4,316,287) |
|
— |
Granted during the
period2 |
924,786 |
|
3,067,596 |
Vested
during the period3 |
(496,240) |
|
(281,498) |
Outstanding at the end of the period |
4,733,499 |
|
8,621,240 |
Weighted average fair value of awards granted ($) |
14.8 |
|
6.8 |
1) As part of the Group's share reorganisation post IPO,
128,541,114 Ordinary Shares of $0.000165 were consolidated into
68,375,690 Ordinary Shares of $0.001551 at a conversion rate of
1:88 to 1 (Refer to note 12 'Share Capital' for further detail.
This adjustment reflects the impact on the schemes listed
above.
2) This represents two new grants which form part of the Group's
long term incentive plans.
3) Amounts vested during the period represent two tranches of
deferred bonus plans.
19 Events after Condensed Consolidated Statement of
Financial Position Date
(a) Dividends
An interim dividend of $10.0m was approved for payment in Q3
2024.
(b) Acquisition of Cowen Asia Limited and Cowen and
Company (Asia) Limited
The Group completed the acquisition of Cowen Asia Limited
(“CAL”) and Cowen and Company (Asia) Limited (“CCAL”) on 2 July
2024 from Toronto Dominion International Pte Ltd. Both CAL and CCAL
are companies incorporated in Hong Kong, and were purchased for a
total consideration of $3.5m which is the equivalent of the net
assets of the two entities. This transaction is the final part of
the Group’s acquisition of Cowen’s prime service and outsourced
trading business from TD Cowen with the business of both entities
having been purchased as a part of the main acquisition completed
on 1 December 2023.
Enquiries please contact:
Marex
Investors - Robert Coates
+44 7880 486329 / rcoates@marex.com
Media - FTI Consulting US / UK
+1 (919) 609-9423 / +44 (0) 7776 111 222 | marex@fticonsulting.com
Marex (NASDAQ:MRX)
Gráfico Histórico do Ativo
De Out 2024 até Nov 2024
Marex (NASDAQ:MRX)
Gráfico Histórico do Ativo
De Nov 2023 até Nov 2024